Cardiotonic; Diuretic; Hypotensive
Turkey; Afghanistan; Ukraine; Iran; Turkmenistan; Pakistan; Kazakhstan; South Africa; Mongolia; Uzbekistan; Tajikistan; China; Japan; Italy; Iraq; Cyprus; Russia; Bulgaria
Ingredient ID: NPC9465
Ingredient ID: NPC94610
Ingredient ID: NPC92774
Ingredient ID: NPC88789
Ingredient ID: NPC88566
Ingredient ID: NPC81775
Ingredient ID: NPC78263
Ingredient ID: NPC78260
Ingredient ID: NPC76336
Ingredient ID: NPC67037
Ingredient ID: NPC61477
Ingredient ID: NPC44963
Ingredient ID: NPC42760
Ingredient ID: NPC3855
Ingredient ID: NPC36108
Ingredient ID: NPC34071
Ingredient ID: NPC322951
Ingredient ID: NPC321290
Ingredient ID: NPC318641
Ingredient ID: NPC318632
Ingredient ID: NPC317111
Ingredient ID: NPC302857
Ingredient ID: NPC294902
Ingredient ID: NPC288245
Ingredient ID: NPC285241
Ingredient ID: NPC281131
Ingredient ID: NPC281128
Ingredient ID: NPC278068
Ingredient ID: NPC275463
Ingredient ID: NPC268342
Ingredient ID: NPC268266
Ingredient ID: NPC263809
Ingredient ID: NPC261619
Ingredient ID: NPC255615
Ingredient ID: NPC252558
Ingredient ID: NPC251619
Ingredient ID: NPC250069
Ingredient ID: NPC238254
Ingredient ID: NPC236202
Ingredient ID: NPC235260
Ingredient ID: NPC220825
Ingredient ID: NPC219876
Ingredient ID: NPC20791
Ingredient ID: NPC20654
Ingredient ID: NPC197396
Ingredient ID: NPC196839
Ingredient ID: NPC196745
Ingredient ID: NPC195940
Ingredient ID: NPC195938
Ingredient ID: NPC19256
Ingredient ID: NPC192173
Ingredient ID: NPC186042
Ingredient ID: NPC18211
Ingredient ID: NPC180079
Ingredient ID: NPC179950
Ingredient ID: NPC176740
Ingredient ID: NPC170083
Ingredient ID: NPC169749
Ingredient ID: NPC167976
Ingredient ID: NPC167114
Ingredient ID: NPC161171
Ingredient ID: NPC159730
Ingredient ID: NPC15658
Ingredient ID: NPC154777
Ingredient ID: NPC154172
Ingredient ID: NPC148504
Ingredient ID: NPC145059
Ingredient ID: NPC145038
Ingredient ID: NPC144956
Ingredient ID: NPC138299
Ingredient ID: NPC137153
Ingredient ID: NPC135391
Ingredient ID: NPC135088
Ingredient ID: NPC133671
Ingredient ID: NPC12987
Ingredient ID: NPC126029
Ingredient ID: NPC124083
Ingredient ID: NPC116775
Ingredient ID: NPC115850
Ingredient ID: NPC110942
Ingredient ID: NPC1075
Ingredient ID: NPC103619
Ingredient ID: NPC100980
Target Type | Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|---|
Therapeutic Target | Cysteine protease | CASP6 | Caspase-6 | P55212 | CHEMBL3308 |
Cytochrome P450 | Cytochrome P450 family 1 | CYP1A1 | Cytochrome P450 1A1 | P04798 | CHEMBL2231 |
Cytochrome P450 | Cytochrome P450 family 1 | CYP1B1 | Cytochrome P450 1B1 | Q16678 | CHEMBL4878 |
Cytochrome P450 | Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Therapeutic Target | Enzyme | RECQL | ATP-dependent DNA helicase Q1 | P46063 | CHEMBL1293236 |
Therapeutic Target | Enzyme | POLB | DNA polymerase beta | P06746 | CHEMBL2392 |
Therapeutic Target | Enzyme | APEX1 | DNA-(apurinic or apyrimidinic site) lyase | P27695 | CHEMBL5619 |
Therapeutic Target | Enzyme | NOX4 | NADPH oxidase 4 | Q9NPH5 | CHEMBL1250375 |
Therapeutic Target | Enzyme | ALOX12 | Arachidonate 12-lipoxygenase | P18054 | CHEMBL3687 |
Therapeutic Target | Enzyme | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | P05186 | CHEMBL5979 |
Therapeutic Target | Hydrolase | ACHE | Acetylcholinesterase | P22303 | CHEMBL220 |
Therapeutic Target | Isomerase | TOP2A | DNA topoisomerase II alpha | P11388 | CHEMBL1806 |
Therapeutic Target | Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Therapeutic Target | Lyase | CA4 | Carbonic anhydrase IV | P22748 | CHEMBL3729 |
Therapeutic Target | Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
Therapeutic Target | Lyase | GLO1 | Glyoxalase I | Q04760 | CHEMBL2424 |
Therapeutic Target | Lyase | CA2 | Carbonic anhydrase II | P00918 | CHEMBL205 |
Therapeutic Target | Lyase | CA9 | Carbonic anhydrase IX | Q16790 | CHEMBL3594 |
Therapeutic Target | Metallo protease | MMP9 | Matrix metalloproteinase 9 | P14780 | CHEMBL321 |
Therapeutic Target | Metallo protease | MMP2 | Matrix metalloproteinase-2 | P08253 | CHEMBL333 |
Therapeutic Target | Metallo protease | MMP1 | Matrix metalloproteinase-1 | P03956 | CHEMBL332 |
Therapeutic Target | Methyl-lysine/arginine binding protein | L3MBTL1 | Lethal(3)malignant brain tumor-like protein 1 | Q9Y468 | CHEMBL1287622 |
Therapeutic Target | Methyl-lysine/arginine binding protein | SMN1 | Survival motor neuron protein | Q16637 | CHEMBL1293232 |
Therapeutic Target | Nuclear hormone receptor subfamily 1 | NR1I2 | Pregnane X receptor | O75469 | CHEMBL3401 |
Therapeutic Target | Nuclear hormone receptor subfamily 3 | NR3C1 | Glucocorticoid receptor | P04150 | CHEMBL2034 |
Therapeutic Target | Oxidoreductase | HSD17B10 | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Q99714 | CHEMBL4159 |
Therapeutic Target | Oxidoreductase | HSD17B2 | Estradiol 17-beta-dehydrogenase 2 | P37059 | CHEMBL2789 |
Therapeutic Target | Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Therapeutic Target | Peptide receptor (family A GPCR) | NPSR1 | Neuropeptide S receptor | Q6W5P4 | CHEMBL5162 |
Therapeutic Target | Peptide receptor (family A GPCR) | OPRD1 | Delta opioid receptor | P41143 | CHEMBL236 |
Therapeutic Target | Phosphodiesterase | TDP1 | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | CHEMBL1075138 |
Therapeutic Target | Protein Kinase | YES1 | Tyrosine-protein kinase YES | P07947 | CHEMBL2073 |
Therapeutic Target | Protein Kinase | AURKB | Serine/threonine-protein kinase Aurora-B | Q96GD4 | CHEMBL2185 |
Therapeutic Target | Protein Kinase | FLT3 | Tyrosine-protein kinase receptor FLT3 | P36888 | CHEMBL1974 |
Therapeutic Target | Protein Kinase | MET | Hepatocyte growth factor receptor | P08581 | CHEMBL3717 |
Therapeutic Target | Protein Kinase | CDK1 | Cyclin-dependent kinase 1 | P06493 | CHEMBL308 |
Therapeutic Target | Protein Kinase | KDR | Vascular endothelial growth factor receptor 2 | P35968 | CHEMBL279 |
Therapeutic Target | Protein Kinase | AXL | Tyrosine-protein kinase receptor UFO | P30530 | CHEMBL4895 |
Therapeutic Target | Protein Kinase | PIM1 | Serine/threonine-protein kinase PIM1 | P11309 | CHEMBL2147 |
Therapeutic Target | Protein Kinase | IGF1R | Insulin-like growth factor I receptor | P08069 | CHEMBL1957 |
Therapeutic Target | Transcription factor | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | P19838 | CHEMBL3251 |
Therapeutic Target | Transcription factor | AHR | Aryl hydrocarbon receptor | P35869 | CHEMBL3201 |
Therapeutic Target | Transcription factor | HIF1A | Hypoxia-inducible factor 1 alpha | Q16665 | CHEMBL4261 |
Clinical trials associated with plant from natural product (NP) & plant level:
Clinical trials type | Number of clinical trials | |
---|---|---|
NP level | 347 | |
NCT ID | Title | Condition | Form in clinical use | Associated by plant or compound |
---|---|---|---|---|
NCT01955187 | Sequential Therapy With Tacrolimus and Rituximab in Primary Membranous Nephropathy | kidney disease | Methylprednisolone (NPC144956) | NP level |
NCT03479502 | Intra-articular Doxycycline: A Novel Treatment of Adhesive Capsulitis | frozen shoulder | Methylprednisolone (NPC144956) | NP level |
NCT03368664 | A Study to Evaluate Efficacy, Safety, and Tolerability of Alemtuzumab in Pediatric Patients With RRMS With Disease Activity on Prior DMT | multiple sclerosis | Methylprednisolone (NPC144956) | NP level |
NCT03751592 | Phase Ib/IIa Studies of Chlorogenic Acid for Injection for Safety and Efficacy of Advanced Lung Cancer | lung cancer | Chlorogenic Acid (NPC302857) | NP level |
NCT00241254 | Efficacy of Cyclophosphamide Versus Methylprednisolone in Patients With Secondary Progressive Multiple Sclerosis | chronic progressive multiple sclerosis | Methylprednisolone (NPC144956) | NP level |
NCT02711449 | Preoperative Methylprednisolone to Patients Suspected of Appendicitis Undergoing Laparoscopy | appendicitis | Methylprednisolone (NPC144956) | NP level |
NCT00427388 | Steroids In caRdiac Surgery Trial (SIRS Trial) | inflammation | Methylprednisolone (NPC144956) | NP level |
NCT00595335 | Trial of Rituximab for Graves' Ophthalmopathy | Graves ophthalmopathy | Methylprednisolone (NPC144956) | NP level |
NCT00003336 | Pilot Study Of Unrelated UCB Transplant for Non-Malignant Hematologic Conditions | myelodysplastic syndrome;myelodysplastic/myeloproliferative disease;leukemia | Methylprednisolone (NPC144956) | NP level |
NCT01986998 | Study to Compare the Clinical and Radiological Efficacy of 625 mg Versus 1250 mg of Oral Methylprednisolone in Patients With Multiple Sclerosis in Relapse | multiple sclerosis | Methylprednisolone (NPC144956) | NP level |
NCT04221477 | A Study To Evaluate The Efficacy And Safety Of Obinutuzumab In Patients With ISN/RPS 2003 Class III Or IV Lupus Nephritis | lupus nephritis | Methylprednisolone (NPC144956) | NP level |
NCT03943459 | Sirtuin-1 and Advanced Glycation End-products in Postmenopausal Women With Coronary Disease | coronary artery disease | Quercetin (NPC20791) | NP level |
NCT02921555 | Endovenous Corticosteroid Pulses in Moderate Ulcerative Colitis | ulcerative colitis | Methylprednisolone (NPC144956) | NP level |
NCT03564106 | Intra-articular Pulsed Radiofrequency With Steroids Injection Versus Intra-articular Steroids Injection in Chronic Sacroiliac Joint Arthritis | pain | Methylprednisolone (NPC144956) | NP level |
NCT02569437 | Doxycycline in Treating Patients With Chronic Rhinosinusitis With Nasal Polyps | polyp | Methylprednisolone (NPC144956) | NP level |
NCT03308084 | Use of Local Intraoperative Steroid in MIS TLIF | specific language disorder | Methylprednisolone (NPC144956) | NP level |
NCT02790788 | Physiologic Effects of Steroids in Cardiac Arrest | cardiac arrest | Methylprednisolone (NPC144956) | NP level |
NCT03249844 | Paediatric Arteriopathy Steroid Aspirin Project | Ischemic stroke | Methylprednisolone (NPC144956) | NP level |
NCT02964377 | Plus Epicatechin Duchenne Muscular Dystrophy in Non-ambulatory Adolescents | Duchenne muscular dystrophy | (+)-Epicatechin (NPC261619) | NP level |
NCT00136903 | Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD) | graft versus host disease | Methylprednisolone (NPC144956) | NP level |
NCT00006451 | Bone Marrow Transplantation in Treating Patients With Leukemia | graft versus host disease;leukemia;lymphoma | Methylprednisolone (NPC144956) | NP level |
NCT00000146 | Optic Neuritis Treatment Trial (ONTT) | optic neuritis | Methylprednisolone (NPC144956) | NP level |
NCT01465334 | Ofatumumab With High Dose Methylprednisone Followed by Ofatumumab and Alemtuzumab in 17p CLL | chronic lymphocytic leukemia | Methylprednisolone (NPC144956) | NP level |
NCT02060656 | Phase II Study Comparing LR-GEM to R-GEM-P in Second-line Treatment of Diffuse Large B-cell Lymphoma (LEGEND) | diffuse large B-cell lymphoma | Methylprednisolone (NPC144956) | NP level |
NCT01496976 | Ofatumumab, High Dose Methylprednisolone, Ofatumumab and Lenalidomide Consolidative Therapy for Untreated CLL/SLL | chronic lymphocytic leukemia | Methylprednisolone (NPC144956) | NP level |
NCT00076752 | Lymphocyte Depletion and Stem Cell Transplantation to Treat Severe Systemic Lupus Erythematosus | systemic lupus erythematosus | Methylprednisolone (NPC144956) | NP level |
NCT00005898 | Phase I/II Study of Total Body Irradiation, Cyclophosphamide, and Fludarabine Followed by Alternate Donor Hematopoietic Cell Transplantation in Patients With Fanconi's Anemia | Fanconi anemia | Methylprednisolone (NPC144956) | NP level |
NCT02887976 | Extension of SoluMatrix TM Abiraterone Acetate in Patients Who Completed Study Number CHL-AA-201 | prostate cancer | Methylprednisolone (NPC144956) | NP level |
NCT03593902 | Cardiac Safe Transplants for Systemic Sclerosis | systemic scleroderma | Methylprednisolone (NPC144956) | NP level |
NCT01114503 | A Safety and Tolerability Study of Otelixizumab in Thyroid Eye Disease | Graves ophthalmopathy | Methylprednisolone (NPC144956) | NP level |
NCT04244591 | Glucocorticoid Therapy for COVID-19 Critically Ill Patients With Severe Acute Respiratory Failure | COVID-19 | Methylprednisolone (NPC144956) | NP level |
NCT00282503 | Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Acute Graft Versus-Host Disease | acute graft vs. host disease | Methylprednisolone (NPC144956) | NP level |
NCT00043147 | Beclomethasone Plus Prednisone in Treating Patients With Graft-Versus-Host Disease | graft versus host disease | Methylprednisolone (NPC144956) | NP level |
NCT03829566 | Autologous Transplant To End NMO Spectrum Disorder | neuromyelitis optica | Methylprednisolone (NPC144956) | NP level |
NCT01105650 | Allogeneic Natural Killer (NK) Cells for Ovarian, Fallopian Tube, Peritoneal and Metastatic Breast Cancer | breast cancer;fallopian tube cancer;ovarian cancer | Methylprednisolone (NPC144956) | NP level |
NCT05137496 | Ruxolitinib and Methylprednisolone as a First-line Treatment for Macrophage Activation Syndrome | macrophage activation syndrome | Methylprednisolone (NPC144956) | NP level |
NCT01332617 | Phase II Study of Simvastatin for Relapsed/Refractory Myeloma | multiple myeloma | Methylprednisolone (NPC144956) | NP level |
NCT04127578 | Phase 1/2a Clinical Trial of PR001 (LY3884961) in Patients With Parkinson's Disease With at Least One GBA1 Mutation (PROPEL) | Parkinson disease | Methylprednisolone (NPC144956) | NP level |
NCT02446795 | Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-line Sunitinib: a Phase I/II Trial | renal cell carcinoma | Isoquercetin (NPC179950) | NP level |
NCT02651350 | Efficacy and Safety of Glucocorticosteroid Treatment in the Patients With Chronic Recurrent DILI | drug-induced hepatitis | Methylprednisolone (NPC144956) | NP level |
NCT03110822 | A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients | multiple myeloma | Methylprednisolone (NPC144956) | NP level |
NCT01708278 | Beneficial Effects of Quercetin in Chronic Obstructive Pulmonary Disease (COPD) | chronic obstructive pulmonary disease | Quercetin (NPC20791) | NP level |
NCT03371498 | Procollagen-3 Driven Corticosteroids for Persistent Acute Respiratory Distress Syndrome | acute respiratory distress syndrome | Methylprednisolone (NPC144956) | NP level |
NCT04519476 | Selinexor Treatment for Multiple Myeloma Patients Who Are Refractory to Lenalidomide-containing Therapy. | multiple myeloma | Methylprednisolone (NPC144956) | NP level |
NCT04163536 | Comparison of Corticosteroids Versus Placebo on Duration of Ventilatory Support During Severe Acute Exacerbations of COPD Patients in the Intensive Care Unit | chronic obstructive pulmonary disease | Methylprednisolone (NPC144956) | NP level |
NCT01348204 | Nasal Potential Studies Utilizing Cystic Fibrosis Transmembrane Regulator (CFTR) Modulators | cystic fibrosis | Quercetin (NPC20791) | NP level |
NCT04438980 | Glucocorticoids in COVID-19 (CORTIVID) | COVID-19 | Methylprednisolone (NPC144956) | NP level |
NCT02445898 | Effect of Methylprednisolone on Orthostatic Intolerance and Heart Rate Variability in Hip-arthroplasty Patients | osteoarthritis | Methylprednisolone (NPC144956) | NP level |
NCT04909918 | Impact of Steroids on Inflammatory Response in Covid-19 | COVID-19 | Methylprednisolone (NPC144956) | NP level |
NCT00003960 | Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer | myelodysplastic syndrome;leukemia;multiple myeloma | Methylprednisolone (NPC144956) | NP level |
NCT03219359 | Autologous Stem Cell Transplant for Crohn's Disease | Crohn's disease | Methylprednisolone (NPC144956) | NP level |
NCT04224558 | Stem Cell Transplantation in Crohn's Disease | Crohn's disease | Methylprednisolone (NPC144956) | NP level |
NCT02330276 | Early Phase Pre-Clinical and Initial Clinical Research on Epicatechin | prediabetes syndrome | (+)-Epicatechin (NPC261619) | NP level |
NCT00381810 | A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus | systemic lupus erythematosus | Methylprednisolone (NPC144956) | NP level |
NCT02087813 | Pilot Study of alpha1-antitrypsin to Treat Neuromyelitis Optica Relapses | neuromyelitis optica | Methylprednisolone (NPC144956) | NP level |
NCT02462252 | Phase IIA Open Label Study to Evaluate Efficacy and Safety of BL-8040 Followed by (hATG), Cyclosporine and Methyprednisolone in Adult Subjects With Aplastic Anemia or Hypoplastic Myelodysplastic Syndrome | Aplastic anemia;myelodysplastic syndrome | Methylprednisolone (NPC144956) | NP level |
NCT01305837 | Cyclic Oral Methylprednisolone Trial in Multiple Sclerosis | multiple sclerosis | Methylprednisolone (NPC144956) | NP level |
NCT03266146 | 36 Weeks Short-Term Optimization Treatment of Glucocorticosteroid in the Patients With Chronic Recurrent DILI | drug-induced hepatitis | Methylprednisolone (NPC144956) | NP level |
NCT01085097 | A Study of Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus Nephritis | lupus nephritis | Methylprednisolone (NPC144956) | NP level |
NCT00561067 | Evaluation of Tolerability and Efficacy of Erythropoietin (EPO) Treatment in Spinal Shock: Comparative Study Versus Methylprednisolone (MP) | Spinal cord injury | Methylprednisolone (NPC144956) | NP level |
NCT03701698 | Ruxolitinib and Steroid as First Line Therapy for Acute GVHD | acute graft vs. host disease | Methylprednisolone (NPC144956) | NP level |
NCT00299130 | A Study to Evaluate the Safety and Efficacy of Rituximab in Combination With Methotrexate Compared to Methotrexate Alone in Patients With Active Rheumatoid Arthritis | rheumatoid arthritis | Methylprednisolone (NPC144956) | NP level |
NCT00379431 | A Protocol Based Treatment for Early and Severe Systemic Sclerosis With (Anti-CD20), Rituximab | systemic scleroderma | Methylprednisolone (NPC144956) | NP level |
NCT04514510 | Fixed Dose Flavonoid Isoquercetin on Thrombo-Inflammatory Biomarkers in Subjects With Stable Sickle Cell Disease | sickle cell anemia | Isoquercetin (NPC179950) | NP level |
NCT00808210 | A Study to Evaluate Ocrelizumab in Combination With Methotrexate Compared With Infliximab Plus Methotrexate in Patients With Active Rheumatoid Arthritis Currently Responding Inadequately to Etanercept or Adalimumab | rheumatoid arthritis | Methylprednisolone (NPC144956) | NP level |
NCT01710228 | Alternative Treatment Paradigm for Natalizumab Trial | multiple sclerosis | Methylprednisolone (NPC144956) | NP level |
NCT01989897 | Effect of HSA or Saline Diluent on Immunotherapy Extract Stability as Determined by Graded ID Skin Tests | allergic rhinitis | Phenol (NPC100980) | NP level |
NCT02956122 | A Phase 2/3 Study of GLASSIA for the Treatment of Acute GvHD | graft versus host disease | Methylprednisolone (NPC144956) | NP level |
NCT05062486 | A Study to Evaluate the Safety and Efficacy of RQC for AMD | age-related macular degeneration | Quercetin (NPC20791) | NP level |
NCT01005914 | Pegaspargase and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | leukemia | Methylprednisolone (NPC144956) | NP level |
NCT02944045 | Effect of Steroids During Pneumocystis Infection Among Non HIV Immunocompromised Patients | hematopoietic and lymphoid cell neoplasm | Methylprednisolone (NPC144956) | NP level |
NCT00323960 | Five-year Actively Controlled Clinical Trial in New Onset Juvenile Dermatomyositis | juvenile dermatomyositis | Methylprednisolone (NPC144956) | NP level |
NCT00771875 | Randomized Trial for Mixed Acute Rejection | acute graft vs. host disease | Methylprednisolone (NPC144956) | NP level |
NCT05139849 | VAsopressin and STeroids in Addition to Adrenaline in Cardiac Arrest - a Randomized Clinical Trial | cardiac arrest | Methylprednisolone (NPC144956) | NP level |
NCT00947895 | Efficacy Study of Adrenocorticotropin Hormone to Treat Multiple Sclerosis (MS) Relapses After Sub-responding to an Initial 3 Day Course of Intravenous (IV) Methylprednisolone | multiple sclerosis | Methylprednisolone (NPC144956) | NP level |
NCT04220632 | A Study of IBI377 in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease | acute graft vs. host disease | Methylprednisolone (NPC144956) | NP level |
NCT02422368 | The Effect of a New Antioxidant Combination (ASTED) on Moderate to Severe Thyroid Eye Disease | Graves ophthalmopathy | Methylprednisolone (NPC144956) | NP level |
NCT03797872 | Psoriatic Oligoarthritis Intervention With Symptomatic thErapy | psoriatic arthritis | Methylprednisolone (NPC144956) | NP level |
NCT02002663 | Continuous Local Anesthetic and Steroid Infusion in Abdominal Surgery | Abdominal pain | Methylprednisolone (NPC144956) | NP level |
NCT01219933 | A Study of Glucocorticoid Use to Evaluate Systematic Methylprednisolone Reduction in Patients With Rheumatoid Arthritis on Background RoActemra/Actemra (Tocilizumab) (ACT-ALONE) | rheumatoid arthritis | Methylprednisolone (NPC144956) | NP level |
NCT04603729 | Comparison of Efficacy of Dexamethasone and Methylprednisolone in Moderate to Severe Covid 19 Disease | COVID-19 | Methylprednisolone (NPC144956) | NP level |
NCT00438087 | Corticosteroids in Prevention of Facial Palsy After Cranial Base Surgery | Bell's palsy | Methylprednisolone (NPC144956) | NP level |
NCT02283996 | Adhesive Capsulitis: Prospective Analysis of Efficacy and Financial Impact for Use of Physical Therapy in Treatment | frozen shoulder | Methylprednisolone (NPC144956) | NP level |
NCT00002599 | Combination Chemotherapy and Interferon Alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma | multiple myeloma | Methylprednisolone (NPC144956) | NP level |
NCT04673162 | Evaluation of the Efficacy of High Doses of Methylprednisolone in SARS-CoV2 ( COVID-19) Pneumonia Patients | COVID-19 | Methylprednisolone (NPC144956) | NP level |
NCT00753792 | Oral Corticotherapy in Megadoses to Treat Multiple Sclerosis During Relapse | multiple sclerosis | Methylprednisolone (NPC144956) | NP level |
NCT02260934 | Rituximab and Belimumab for Lupus Nephritis | lupus nephritis | Methylprednisolone (NPC144956) | NP level |
NCT04074187 | A Trial of Caplacizumab in Japanese Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP) | thrombotic thrombocytopenic purpura | Methylprednisolone (NPC144956) | NP level |
NCT00003650 | Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma | lymphoma | Methylprednisolone (NPC144956) | NP level |
NCT05232825 | A Phase III, Non-Inferiority, Randomized, Open-Label, Parallel Group, Multicenter Study To Investigate The Pharmacokinetics, Pharmacodynamics, Safety And Radiological And Clinical Effects Of Subcutaneous Ocrelizumab Versus Intravenous Ocrelizumab In Patients With Multiple Sclerosis | primary progressive multiple sclerosis | Methylprednisolone (NPC144956) | NP level |
NCT04536090 | Study of Isoquercetin (IQC-950AN) Plus Standard of Care Versus Standard of Care Only for the Treatment of COVID-19 | COVID-19 | Isoquercetin (NPC179950) | NP level |
NCT05220319 | CORTERAS STUDY: The Effect of Corticosteroids on Early Recovery After Major Surgery in Elderly Patients | inflammation | Methylprednisolone (NPC144956) | NP level |
NCT01690676 | Effect of an Apple Polyphenol Extract on Brachial Artery Flow-mediated Vasodilatory Function | hypertension | (+)-Epicatechin (NPC261619) | NP level |
NCT01705652 | Study to Assess the Activity of Nexrutine® in Prostate Cancer Patients | prostate cancer | Rutin (NPC176740) | NP level |
NCT02424435 | Methylprednisolone Treatment of Friedreich Ataxia | Friedreich ataxia | Methylprednisolone (NPC144956) | NP level |
NCT04622865 | Masitinib Combined With Isoquercetin and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19 | COVID-19 | Isoquercetin (NPC179950) | NP level |
NCT00017628 | Phase I Study of High-Dose Cyclophosphamide and Total Body Irradiation With T Lymphocyte-Depleted Autologous Peripheral Blood Stem Cell or Bone Marrow Rescue in Patients With Multiple Sclerosis | multiple sclerosis | Methylprednisolone (NPC144956) | NP level |
NCT00282347 | A Study to Evaluate the Efficacy and Safety of Rituximab in Subjects With International Society of Nephrology/Renal Pathology Society (ISN/RPS) 2003 Class III or IV Lupus Nephritis | lupus nephritis | Methylprednisolone (NPC144956) | NP level |
NCT00157014 | Canadian Cardiology de Novo Study: A Comparison Between Tacrolimus- and Cyclosporine- Based Immunoprophylactic Regimens | heart disease | Methylprednisolone (NPC144956) | NP level |
NCT01390441 | A Study of the Pharmacokinetics and Safety of MK-8808 (MK-8808-002) | rheumatoid arthritis | Methylprednisolone (NPC144956) | NP level |
NCT04648917 | GASC1 Inhibitor Caffeic Acid for Squamous Esophageal Cell Cancer (ESCC) | esophageal cancer | Caffeic Acid (NPC294902) | NP level |
NCT02049073 | Prevention of Noise-induced Hearing Loss | noise-induced hearing loss | Methylprednisolone (NPC144956) | NP level |
NCT00069966 | Pixantrone, Cytarabine, Methylprednisolone, and Cisplatin in Treating Patients With Aggressive Non-Hodgkin's Lymphoma in First Relapse | lymphoma | Methylprednisolone (NPC144956) | NP level |
NCT02542592 | Effect of Methylprednisolone on Immune Signaling in Hip-arthroplasty Patients | osteoarthritis | Methylprednisolone (NPC144956) | NP level |
NCT00802529 | Transtympanic Gentamicin vs. Steroids in Refractory Meniere's Disease | Meniere disease | Methylprednisolone (NPC144956) | NP level |
NCT01838174 | A Trial of Neuroprotection With ACTH in Acute Optic Neuritis | multiple sclerosis | Methylprednisolone (NPC144956) | NP level |
NCT00004785 | Phase III Randomized, Double-Blind Study of Dexamethasone Vs Dexamethasone/Methylprednisolone Vs Placebo for Bronchopulmonary Dysplasia | bronchopulmonary dysplasia | Methylprednisolone (NPC144956) | NP level |
NCT00002524 | Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma | Lymphoma, AIDS-Related | Methylprednisolone (NPC144956) | NP level |
NCT00436761 | Busulfan, Melphalan, and Antithymocyte Globulin Followed By Umbilical Cord Blood Transplant in Treating Young Patients With Refractory or Relapsed Malignant Solid Tumors | neoplasm | Methylprednisolone (NPC144956) | NP level |
NCT02532777 | The Research of Standard Diagnosis and Treatment for HSPN in Children | Henoch-Schoenlein purpura | Methylprednisolone (NPC144956) | NP level |
NCT02552888 | Nitrite, Isoquercetin and Endothelial Dysfunction (NICE) Trial | chronic kidney disease | Isoquercetin (NPC179950) | NP level |
NCT00135967 | Mycophenolate Mofetil in Membranous Nephropathy | membranous glomerulonephritis | Methylprednisolone (NPC144956) | NP level |
NCT01197040 | Evaluation of Low Dose Corticosteroids Efficiency, Associated With Myfortic ® in the Treatment of Nephrotic Syndrome | nephrotic syndrome | Phenol (NPC100980) | NP level |
NCT00128180 | Efficacy of Methylprednisolone for Hantavirus Cardiopulmonary Syndrome | Hantavirus infectious disease | Methylprednisolone (NPC144956) | NP level |
NCT02545959 | Intrathecal Rituximab in Progressive Multiple Sclerosis | chronic progressive multiple sclerosis | Methylprednisolone (NPC144956) | NP level |
NCT01375101 | Therapeutic Effect of Quercetin and the Current Treatment of Erosive and Atrophic Oral Lichen Planus | oral lichen planus | Quercetin (NPC20791) | NP level |
NCT03311425 | Effect of Local Intraoperative Steroid on Dysphagia After ACDF | Dysphagia | Methylprednisolone (NPC144956) | NP level |
NCT04787744 | Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for OligoRecurrenT Prostate Cancer | metastatic prostate cancer | Methylprednisolone (NPC144956) | NP level |
NCT00577993 | Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients | lymphoma | Methylprednisolone (NPC144956) | NP level |
NCT02332603 | Effect of Methylprednisolone on Glucose Homeostasis in Patients Undergoing Total Hip- and Knee-arthroplasty | osteoarthritis | Methylprednisolone (NPC144956) | NP level |
NCT00002471 | Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma | leukemia;lymphoma | Methylprednisolone (NPC144956) | NP level |
NCT04876534 | Tocilizumab in Active Moderate-severe Graves' Orbitopathy | Graves ophthalmopathy | Methylprednisolone (NPC144956) | NP level |
NCT05368181 | MAP-guided Preemptive Therapy of aGvHD | acute graft vs. host disease | Methylprednisolone (NPC144956) | NP level |
NCT04355247 | Prophylactic Corticosteroid to Prevent COVID-19 Cytokine Storm | COVID-19 | Methylprednisolone (NPC144956) | NP level |
NCT00310128 | Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma | anaplastic large cell lymphoma;Lymphoma, AIDS-Related | Methylprednisolone (NPC144956) | NP level |
NCT02953678 | A Study of Ruxolitinib in Combination With Corticosteroids for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease (REACH-1) | graft versus host disease | Methylprednisolone (NPC144956) | NP level |
NCT01000610 | A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate | rheumatoid arthritis | Methylprednisolone (NPC144956) | NP level |
NCT00000741 | The Safety and Effectiveness of Methylprednisolone in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Children With AIDS | pneumocystosis | Methylprednisolone (NPC144956) | NP level |
NCT03387046 | A Pilot Study in Participants With Relapsing Remitting Multiple Sclerosis (RR-MS) | relapsing-remitting multiple sclerosis | Methylprednisolone (NPC144956) | NP level |
NCT03007147 | Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia | T-cell acute lymphoblastic leukemia | Methylprednisolone (NPC144956) | NP level |
NCT00299104 | A Study to Evaluate Rituximab in Combination With Methotrexate in Methotrexate-Naive Patients With Active Rheumatoid Arthritis | rheumatoid arthritis | Methylprednisolone (NPC144956) | NP level |
NCT01884571 | Immunosuppression in Amyotrophic Lateral Sclerosis (ALS) | amyotrophic lateral sclerosis | Methylprednisolone (NPC144956) | NP level |
NCT00920153 | Three Different Therapy Regimens in Treating Patients With Previously Untreated Hodgkin Lymphoma | lymphoma | Methylprednisolone (NPC144956) | NP level |
NCT02650609 | Treatment of Chronic Subdural Hematoma by Corticosteroids | intracranial subdural hematoma | Methylprednisolone (NPC144956) | NP level |
NCT00630253 | Cytoxan, Fludara, and Antithymocyte Globulin Conditioning Followed By Stem Cell Transplant in Treating Fanconi Anemia | Fanconi anemia | Methylprednisolone (NPC144956) | NP level |
NCT04499313 | Dexamethasone Vs Methylprednisolone for the Treatment of Patients With ARDS Caused by COVID-19 | COVID-19;severe acute respiratory syndrome | Methylprednisolone (NPC144956) | NP level |
NCT01283009 | Extended Steroid in Use in Community Acquired Pneumonia (CAP)(e) | respiratory system disease | Methylprednisolone (NPC144956) | NP level |
NCT05002517 | Randomized, Unicentric, Open, Controlled Clinical Trial, in Phase Iii, to Demonstrate the Effectiveness of Tocilizumab | COVID-19 | Methylprednisolone (NPC144956) | NP level |
NCT04345445 | Study to Evaluate the Efficacy and Safety of Tocilizumab Versus Corticosteroids in Hospitalised COVID-19 Patients With High Risk of Progression | COVID-19 | Methylprednisolone (NPC144956) | NP level |
NCT04963296 | A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With Systemic Lupus Erythematosus | systemic lupus erythematosus | Methylprednisolone (NPC144956) | NP level |
NCT02245204 | Phase I Studies of Chlorogenic Acid for Injection for Tolerance and Pharmacokinetic of Advanced Cancers | cancer | Chlorogenic Acid (NPC302857) | NP level |
NCT04323592 | Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome | coronavirus infectious disease;COVID-19;severe acute respiratory syndrome | Methylprednisolone (NPC144956) | NP level |
NCT05487521 | EEG Changes in Pediatrics With Language Dysfunction Evaluation of Sleep EEG Changes in Paediatric Patients With Language Dysfunction: A Follow up Study. EEG Changes in Pediatrics With Language Dysfunction | language disorder | Methylprednisolone (NPC144956) | NP level |
NCT00078559 | Combination Immunosuppressive Therapy to Prevent Kidney Transplant Rejection in Adults | kidney disease | Methylprednisolone (NPC144956) | NP level |
NCT01046786 | Safety and Feasibility of Umbilical Cord Blood Cell Transplant Into Injured Spinal Cord | Spinal cord injury | Methylprednisolone (NPC144956) | NP level |
NCT04386304 | Safety and Biomarker Response to (+)-Epicatechin in Becker Muscular Dystrophy | Becker muscular dystrophy | (+)-Epicatechin (NPC261619) | NP level |
NCT02093026 | Extension Study to Assess the Efficacy and Safety of Repeat Treatment With Rituximab (MabThera) in Participants With Active Rheumatoid Arthritis (RA) | rheumatoid arthritis | Methylprednisolone (NPC144956) | NP level |
NCT04544436 | A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS) | multiple sclerosis | Methylprednisolone (NPC144956) | NP level |
NCT00787722 | Hematopoietic Stem Cell Transplant in Devic's Disease | neuromyelitis optica | Methylprednisolone (NPC144956) | NP level |
NCT03704584 | Corticosteroid(CS) + Lido or Corticosteroid(CS) Alone | tenosynovitis | Methylprednisolone (NPC144956) | NP level |
NCT00609609 | Photopheresis for the Treatment of Acute Graft Versus Host Disease | graft versus host disease | Methylprednisolone (NPC144956) | NP level |
NCT04485429 | Efficacy Assessment of Methylprednisolone and Heparin in Patients With COVID-19 Pneumonia | COVID-19 | Methylprednisolone (NPC144956) | NP level |
NCT00400946 | Treatment of Acute Lymphoblastic Leukemia in Children | leukemia | Methylprednisolone (NPC144956) | NP level |
NCT02332629 | Effect of Methylprednisolone on Endothelial Function in Patients Undergoing Total Knee-arthroplasty | osteoarthritis | Methylprednisolone (NPC144956) | NP level |
NCT05422885 | Safety and Feasibility of Dasatinib and Quercetin in Adults at Risk for Alzheimer's Disease | aging | Quercetin (NPC20791) | NP level |
NCT00000730 | Comparison of Three Treatments for Pneumocystis Pneumonia in AIDS Patients | pneumocystosis | Methylprednisolone (NPC144956) | NP level |
NCT04294459 | Safety, Pharmacokinetics, and Preliminary Efficacy of Isatuximab in Patients Awaiting Kidney Transplantation | immune system disease | Methylprednisolone (NPC144956) | NP level |
NCT02621060 | Effect of Chlorogenic Acid on Patients With Impaired Glucose Tolerance | abnormal glucose tolerance | Chlorogenic Acid (NPC302857) | NP level |
NCT02656212 | Early Phase Pre-Clinical and Initial Clinical Research on Epicatechin (Part 2) | prediabetes syndrome | (+)-Epicatechin (NPC261619) | NP level |
NCT04873583 | High Dose Steroids in Children With Stroke | childhood acute lymphoblastic leukemia | Methylprednisolone (NPC144956) | NP level |
NCT01624805 | Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome | Aplastic anemia;myelodysplastic syndrome | Methylprednisolone (NPC144956) | NP level |
NCT05456022 | Therapeutic Efficacy of Quercetin Versus Its Encapsulated Nanoparticle on Tongue Squamous Cell Carcinoma Cell Line | mouth neoplasm | Quercetin (NPC20791) | NP level |
NCT04157036 | Evaluation of Methylprednisolone or Ibuprofen on Efficacy of Nerve Blocks With Symptomatic Irreversible Pulpitis | pulpitis | Methylprednisolone (NPC144956) | NP level |
NCT00104299 | Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis | Granulomatosis with Polyangiitis;microscopic polyangiitis | Methylprednisolone (NPC144956) | NP level |
NCT02282514 | Stem Cell Transplantation for Stiff Person Syndrome (SPS) | Stiff-Person syndrome | Methylprednisolone (NPC144956) | NP level |
NCT02550652 | A Study to Evaluate the Safety and Efficacy of Obinutuzumab Compared With Placebo in Participants With Lupus Nephritis (LN) | lupus nephritis | Methylprednisolone (NPC144956) | NP level |
NCT01308255 | Infliximab as Induction Therapy in Early Rheumatoid Arthritis (IDEA) | rheumatoid arthritis | Methylprednisolone (NPC144956) | NP level |
NCT05150704 | MYTHS - MYocarditis THerapy With Steroids | myocarditis | Methylprednisolone (NPC144956) | NP level |
NCT01647685 | A Proof of Concept Study to Determine the Local Delivery and Efficacy of Nanocort | atherosclerosis | Methylprednisolone (NPC144956) | NP level |
NCT01719835 | CHOP vs GEM-P in 1st Line Treatment of T-cell Lymphoma, Multicentre Phase II Study | anaplastic large cell lymphoma;angioimmunoblastic T-cell lymphoma;unspecified peripheral T-cell lymphoma | Methylprednisolone (NPC144956) | NP level |
NCT01445821 | Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial | systemic scleroderma | Methylprednisolone (NPC144956) | NP level |
NCT00634933 | Study Evaluating 2 Dosing Regimens Of TRU-015 In Rheumatoid Arthritis | rheumatoid arthritis | Methylprednisolone (NPC144956) | NP level |
NCT00357084 | Methotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell Transplant | cancer | Methylprednisolone (NPC144956) | NP level |
NCT00720109 | Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Methylprednisolone (NPC144956) | NP level |
NCT01856868 | Use of (-)-Epicatechin in the Treatment of Becker Muscular Dystrophy (Pilot Study) | Becker muscular dystrophy | (-)-Epicatechin (NPC126029) | NP level |
NCT00977444 | Evaluation of a New Formulation Useful for the Osteoarthrosis Treatment | osteoarthritis | Methylprednisolone (NPC144956) | NP level |
NCT04988425 | TNFα Monoclonal Antibody for Acute Spinal Cord Injury | Spinal cord injury | Methylprednisolone (NPC144956) | NP level |
NCT00574288 | Daratumumab (HuMax®-CD38) Safety Study in Multiple Myeloma | multiple myeloma | Methylprednisolone (NPC144956) | NP level |
NCT02136342 | Phase 1 Trial of Chlorogenic Acid in Patients With Advanced Cancer | cancer | Chlorogenic Acid (NPC302857) | NP level |
NCT03876444 | Intravenous Methylprednisolone Versus Oral Prednisolone for Infantile Spasms | developmental and epileptic encephalopathy | Methylprednisolone (NPC144956) | NP level |
NCT05302388 | A Study Exploring Efficacy of Pegloticase in Subjects With Asymptomatic Hyperuricemia | hyperuricemia | Methylprednisolone (NPC144956) | NP level |
NCT01216631 | Seronegative Oligoarthritis of the Knee Study (SOKS) | spondyloarthropathy | Methylprednisolone (NPC144956) | NP level |
NCT01382940 | A Study on The Safety of Administering Rituximab at A More Rapid Rate in Patients With Rheumatoid Arthritis | rheumatoid arthritis | Methylprednisolone (NPC144956) | NP level |
NCT00002785 | Combination Chemotherapy, Bone Marrow Transplantation, and Radiation Therapy in Treating Infants With Acute Lymphoblastic Leukemia | leukemia | Methylprednisolone (NPC144956) | NP level |
NCT00307645 | IMPROVE: Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy in ANCA Associated Systemic Vasculitis | anti-neutrophil antibody associated vasculitis;Granulomatosis with Polyangiitis;microscopic polyangiitis | Methylprednisolone (NPC144956) | NP level |
NCT00733096 | A 3-arm Multi-center, Randomized Controlled Study Comparing Transforaminal Corticosteroid, Transforaminal Etanercept and Transforaminal Saline for Lumbosacral Radiculopathy | radiculopathy | Methylprednisolone (NPC144956) | NP level |
NCT00002835 | Combination Chemotherapy in Treating Patients With Lymphoma | lymphoma | Methylprednisolone (NPC144956) | NP level |
NCT00230035 | Lupus Immunosuppressive/Immunomodulatory Therapy or Stem Cell Transplant (LIST) | systemic lupus erythematosus | Methylprednisolone (NPC144956) | NP level |
NCT03994783 | Transplant Antibody-Mediated Rejection: Guiding Effective Treatments | acute graft vs. host disease | Methylprednisolone (NPC144956) | NP level |
NCT01014104 | Administration of Methylprednisolone for Prevention of Ovarian Hyper Stimulation Syndrome | ovarian hyperstimulation syndrome | Methylprednisolone (NPC144956) | NP level |
NCT04946383 | Safety and Effectivness of Quercetin & Dasatinib on Epigenetic Aging | aging | Quercetin (NPC20791) | NP level |
NCT03342638 | Maximizing Outcome of Multiple Sclerosis Transplantation | relapsing-remitting multiple sclerosis | Methylprednisolone (NPC144956) | NP level |
NCT02576249 | Corticosteroid/Ropivacaine Versus Corticosteroid/Saline Injections for Knee Osteoarthritis | osteoarthritis | Methylprednisolone (NPC144956) | NP level |
NCT01720147 | Quercetin in Children With Fanconi Anemia; a Pilot Study | Fanconi anemia | Quercetin (NPC20791) | NP level |
NCT04629248 | A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy | kidney disease | Methylprednisolone (NPC144956) | NP level |
NCT01228331 | Clofarabine or High-Dose Cytarabine and Pegaspargase in Children With ALL | leukemia | Methylprednisolone (NPC144956) | NP level |
NCT02660112 | (+) Epicatechin to Treat Friedreich's Ataxia | Friedreich ataxia | (+)-Epicatechin (NPC261619) | NP level |
NCT01941589 | Corticosteroids+5-aminosalicylic Acid Compared to Corticosteroids in the Treatment of Moderate-severe Ulcerative Colitis | ulcerative colitis | Methylprednisolone (NPC144956) | NP level |
NCT05039619 | A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis | lupus nephritis | Methylprednisolone (NPC144956) | NP level |
NCT00004759 | Methylprednisolone Given by 24-Hour or 48-Hour Infusion Versus Tirilazad for Acute Spinal Cord Injury | Spinal cord injury | Methylprednisolone (NPC144956) | NP level |
NCT04851821 | The Effectiveness of Phytotherapy in SARS-COV2(COVID-19) | COVID-19 | Quercetin (NPC20791) | NP level |
NCT01985126 | An Efficacy and Safety Study of Daratumumab in Patients With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor [PI] and Immunomodulatory Drug [IMiD]) or Are Double Refractory to a PI and an IMiD | multiple myeloma | Methylprednisolone (NPC144956) | NP level |
NCT01005758 | Combination Chemotherapy in Treating Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | leukemia | Methylprednisolone (NPC144956) | NP level |
NCT02757196 | Treatment of ITP With Rituximab and / or Accutane | autoimmune thrombocytopenic purpura | Methylprednisolone (NPC144956) | NP level |
NCT04918147 | Elotuzumab in Immunoglobulin G4-Related Disease (IgG4-RD) | IgG4-related disease | Methylprednisolone (NPC144956) | NP level |
NCT00482053 | Phase 2 Poor Risk DLBCL of TLI and ATG Followed by Matched Allogeneic HT as Consolidation to Autologous HCT | diffuse large B-cell lymphoma | Methylprednisolone (NPC144956) | NP level |
NCT00553202 | Donor Stem Cell Transplant in Treating Young Patients With Acute Myeloid Leukemia With Monosomy 7, -5/5q-, High FLT3-ITD AR, or Refractory or Relapsed Acute Myelogenous Leukemia | leukemia | Methylprednisolone (NPC144956) | NP level |
NCT02912702 | L-DEP as an Initial Treatment for EBV-HLH | hemophagocytic syndrome | Methylprednisolone (NPC144956) | NP level |
NCT00806871 | Steroid Injection Treatment of Carpal Tunnel Syndrome | carpal tunnel syndrome | Methylprednisolone (NPC144956) | NP level |
NCT02552342 | Corticosteroid Therapy for Severe Community-Acquired Pneumonia | pneumonia | Methylprednisolone (NPC144956) | NP level |
NCT03952637 | A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis | gangliosidosis | Methylprednisolone (NPC144956) | NP level |
NCT01071083 | Treatment Interruption of Natalizumab | relapsing-remitting multiple sclerosis | Methylprednisolone (NPC144956) | NP level |
NCT02292082 | The Combination of Adductor Canal Block and Periarticular Injection. A Novel Technique for Patients Undergoing Total Knee Replacement (ACB PAI) | osteoarthritis | Methylprednisolone (NPC144956) | NP level |
NCT02392780 | Cannabidiol for the Treatment of Severe (Grades III/IV) Acute Graft-versus-host Disease | acute graft vs. host disease | Methylprednisolone (NPC144956) | NP level |
NCT00753103 | Anti-Cytokine Therapy for Vasculitis | Granulomatosis with Polyangiitis;microscopic polyangiitis | Methylprednisolone (NPC144956) | NP level |
NCT00298272 | Safety and Tolerability of Rituxan With Methotrexate and Etanercept or Methotrexate and Adalimumab in Patients With Active Rheumatoid Arthritis | rheumatoid arthritis | Methylprednisolone (NPC144956) | NP level |
NCT00023244 | Steroid Withdrawal in Pediatric Kidney Transplant Recipients | chronic kidney disease | Methylprednisolone (NPC144956) | NP level |
NCT00004034 | Treatment of Childhood Acute Lymphoblastic Leukemia | leukemia | Methylprednisolone (NPC144956) | NP level |
NCT00984984 | Efficacy and Safety of Methylprednisolone Per os Versus IV for the Treatment of Multiple Sclerosis (MS) Relapses | relapsing-remitting multiple sclerosis | Methylprednisolone (NPC144956) | NP level |
NCT02631109 | L-DEP Regimen as a Salvage Therapy for Refractory Epstein Barr Virus-induced Hemophagocytic Lymphohistiocytosis | hemophagocytic syndrome | Methylprednisolone (NPC144956) | NP level |
NCT05324748 | Repeated GON Injections in CCH | pain | Methylprednisolone (NPC144956) | NP level |
NCT04411654 | Phase 1/2 Clinical Trial of PR001 in Infants With Type 2 Gaucher Disease (PROVIDE) | Gaucher disease type 2 | Methylprednisolone (NPC144956) | NP level |
NCT03852537 | Steroid Dosing by bioMARker Guided Titration in Critically Ill Patients With Pneumonia | pneumonia | Methylprednisolone (NPC144956) | NP level |
NCT01497496 | Ofatumumab/Methylprednisolone and Ofatumumab/Lenalidomide for Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) | chronic lymphocytic leukemia | Methylprednisolone (NPC144956) | NP level |
NCT02331862 | To Study the Effect of Adjunctive Oral Methylprednisolone Therapy in Pediatric Urinary Tract Infection | urinary tract infection | Methylprednisolone (NPC144956) | NP level |
NCT00003682 | Methylprednisolone With or Without Doxorubicin in Treating Patients With Metastatic Prostate Cancer | prostate cancer | Methylprednisolone (NPC144956) | NP level |
NCT03640949 | Vasopressin and Methylprednisolone for In-Hospital Cardiac Arrest | sudden cardiac arrest | Methylprednisolone (NPC144956) | NP level |
NCT04548999 | A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS) | multiple sclerosis | Methylprednisolone (NPC144956) | NP level |
NCT03139604 | GRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host Disease | graft versus host disease | Methylprednisolone (NPC144956) | NP level |
NCT00004232 | Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer | chronic myeloproliferative disorder;myelodysplastic syndrome;graft versus host disease;leukemia;multiple myeloma | Methylprednisolone (NPC144956) | NP level |
NCT00729794 | Vasopressin, Epinephrine, and Steroids for Cardiac Arrest | cardiac arrest | Methylprednisolone (NPC144956) | NP level |
NCT04733651 | Study to Investigate the Clinical Efficacy of Isoquercetin in Patients With COVID-19 | COVID-19 | Isoquercetin (NPC179950) | NP level |
NCT01839344 | Effects of Quercetin on Blood Sugar and Blood Vessel Function in Type 2 Diabetes. | type 2 diabetes mellitus | Quercetin (NPC20791) | NP level |
NCT00003187 | Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma | myelodysplastic syndrome;leukemia;lymphoma | Methylprednisolone (NPC144956) | NP level |
NCT00002565 | Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma | lymphoma | Methylprednisolone (NPC144956) | NP level |
NCT04408625 | Phase 1/2 Clinical Trial of PR006 in Patients With Frontotemporal Dementia With Progranulin Mutations (FTD-GRN) | frontotemporal dementia | Methylprednisolone (NPC144956) | NP level |
NCT00396747 | A Comparison of Methotrexate Alone or Combined to Infliximab or to Pulse Methylprednisolone in Early Rheumatoid Arthritis: A Magnetic Resonance Imaging Study | rheumatoid arthritis | Methylprednisolone (NPC144956) | NP level |
NCT00002534 | Bone Marrow Transplantation in Treating Patients With Acute Leukemia in First or Second Remission | leukemia | Methylprednisolone (NPC144956) | NP level |
NCT05276895 | Effect of Natural Senolytic Agents & NLRP3 Inhibitors on Osteoarthritis | osteoarthritis | Quercetin (NPC20791) | NP level |
NCT02294357 | Weekly 70 mg/m2 Carfilzomib for Multiple Myeloma Patients Refractory to 27 mg/m2 Carfilzomib | multiple myeloma | Methylprednisolone (NPC144956) | NP level |
NCT00278564 | Stem Cell Transplantation in Idiopathic Inflammatory Myopathy Diseases | myopathy | Methylprednisolone (NPC144956) | NP level |
NCT00002718 | T-cell Depleted Bone Marrow and G-CSF Stimulated Peripheral Stem Cell Transplantation From Related Donors in Treating Patients With Leukemia, Lymphoblastic Lymphoma, Myelodysplastic Syndrome, or Aplastic Anemia | myelodysplastic syndrome;myeloproliferative disorder;leukemia;lymphoma | Methylprednisolone (NPC144956) | NP level |
NCT01880866 | (-)-Epicatechin and Pulmonary Arterial Hypertension | pulmonary arterial hypertension | (-)-Epicatechin (NPC126029) | NP level |
NCT02614612 | Study of Itacitinib in Combination With Corticosteroids for the Treatment of Acute GVHD | graft versus host disease | Methylprednisolone (NPC144956) | NP level |
NCT00609739 | Cytosine Arabinoside and Mitoxantrone for Patients With Juvenile Myelomonocytic Leukemia Receiving Repeat Stem Cell Transplantation | leukemia | Methylprednisolone (NPC144956) | NP level |
NCT04329650 | Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID-19 Pneumonia | COVID-19 | Methylprednisolone (NPC144956) | NP level |
NCT01331018 | Gene Therapy for Fanconi Anemia | Fanconi anemia | Methylprednisolone (NPC144956) | NP level |
NCT00623766 | Evaluation of Tumor Response to Ipilimumab in the Treatment of Melanoma With Brain Metastases | melanoma | Methylprednisolone (NPC144956) | NP level |
NCT00966836 | Prevention of Transplant Atherosclerosis With Everolimus and Anti-cytomegalovirus Therapy | cytomegalovirus infection | Phenol (NPC100980) | NP level |
NCT03942887 | Exploring Durable Remission With Rituximab in Antineutrophil Cytoplasmic Antibody(ANCA)-Associated Vasculitis | anti-neutrophil antibody associated vasculitis | Methylprednisolone (NPC144956) | NP level |
NCT02728349 | Tolerance and Pharmacokinetic Study of Chlorogenic Acid to Advanced Glioblastoma | glioblastoma multiforme | Chlorogenic Acid (NPC302857) | NP level |
NCT00004323 | Phase II Study of Bone Marrow Transplantation Using Related Donors in Patients With Aplastic Anemia | Aplastic anemia | Methylprednisolone (NPC144956) | NP level |
NCT00657059 | Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy (IgAN) | IGA glomerulonephritis | Methylprednisolone (NPC144956) | NP level |
NCT00423098 | Efficacy and Safety of Enteric-coated Mycophenolate Sodium in Combination With Two Corticosteroid Regimens for the Treatment of Lupus Nephritis Flare | lupus nephritis | Methylprednisolone (NPC144956) | NP level |
NCT04077905 | Pegylated Liposomal Doxorubicin as a Induction Therapy for Lymphoma Induced Hemophagocytic Lymphohistiocytosis. | hemophagocytic syndrome | Methylprednisolone (NPC144956) | NP level |
NCT00455416 | Dietary Intervention in Follicular Lymphoma | follicular lymphoma | Quercetin (NPC20791) | NP level |
NCT00558181 | High-dose Methylprednisolone and Rituximab in High Risk B-CLL | chronic lymphocytic leukemia | Methylprednisolone (NPC144956) | NP level |
NCT04936854 | Sirolimus vs Corticosteroids in Treatment of Thyroid Eye Disease | Graves ophthalmopathy | Methylprednisolone (NPC144956) | NP level |
NCT02176031 | Phase II Trial of Natalizumab + Prednisone for Initial Therapy of Acute GI GVHD | graft versus host disease | Methylprednisolone (NPC144956) | NP level |
NCT05487599 | A Clinical Trial of PR001 (LY3884961) in Patients With Peripheral Manifestations of Gaucher Disease (PROCEED) | Gaucher disease | Methylprednisolone (NPC144956) | NP level |
NCT00000579 | Acute Respiratory Distress Syndrome Clinical Network (ARDSNet) | adult acute respiratory distress syndrome | Methylprednisolone (NPC144956) | NP level |
NCT00109928 | S0350 Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Peripheral T-Cell Non-Hodgkin's Lymphoma | lymphoma | Methylprednisolone (NPC144956) | NP level |
NCT02226484 | Can Quercetin Increase Claudin-4 and Improve Esophageal Barrier Function in GERD? | gastroesophageal reflux disease | Quercetin (NPC20791) | NP level |
NCT03018535 | Rituximab Versus Steroids and Cyclophosphamide in the Treatment of Idiopathic Membranous Nephropathy | membranous glomerulonephritis | Methylprednisolone (NPC144956) | NP level |
NCT02769689 | Methylprednisolone During the Switch Between Natalizumab and Fingolimod | multiple sclerosis | Methylprednisolone (NPC144956) | NP level |
NCT02584738 | Nebulized Magnesium Sulfate as an Adjunct to Standard Therapy in Asthma Exacerbation | asthma | Methylprednisolone (NPC144956) | NP level |
NCT02319343 | Effect of Methylprednisolone on Quadriceps Muscle Function in Patients Undergoing Total Knee-arthroplasty | osteoarthritis | Methylprednisolone (NPC144956) | NP level |
NCT02784210 | Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques | multiple sclerosis | Methylprednisolone (NPC144956) | NP level |
NCT00243412 | A Study of the Safety and Efficacy of Rituximab in Patients With Moderate to Severe Rheumatoid Arthritis Receiving Methotrexate | rheumatoid arthritis | Methylprednisolone (NPC144956) | NP level |
NCT02332616 | Effect of Methylprednisolone on Complement Activation in Patients Undergoing Total Knee-arthroplasty | osteoarthritis | Methylprednisolone (NPC144956) | NP level |
NCT01220531 | Thymus Transplantation Safety-Efficacy | 22q11.2 deletion syndrome | Methylprednisolone (NPC144956) | NP level |
NCT00578305 | A Study of Rituximab (MabThera®/Rituxan®) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate | rheumatoid arthritis | Methylprednisolone (NPC144956) | NP level |
NCT04509219 | Methylprednisolone Pulse Therapy for Coronary Artery Dilatation or Aneurysm Formation in Kawasaki Disease | mucocutaneous lymph node syndrome | Methylprednisolone (NPC144956) | NP level |
NCT02166463 | Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma | classic Hodgkin lymphoma | Methylprednisolone (NPC144956) | NP level |
NCT01049451 | Pulse ACTH vs. MP for MS | multiple sclerosis | Methylprednisolone (NPC144956) | NP level |
NCT00579527 | Phase I/II Thymus Transplantation With Immunosuppression | 22q11.2 deletion syndrome | Methylprednisolone (NPC144956) | NP level |
NCT01790022 | Efficacy and Safety of MEthylprednisolone Administered Intravenously for the Treatment of Patients With Active AnkyLosing spondyLitis (METALL) | ankylosing spondylitis | Methylprednisolone (NPC144956) | NP level |
NCT04349410 | The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol | COVID-19 | Methylprednisolone (NPC144956) | NP level |
NCT00458848 | Chemotherapy With or Without Imatinib and/or Peripheral Stem Cell Transplant in Acute Lymphoblastic Leukemia | leukemia | Methylprednisolone (NPC144956) | NP level |
NCT00376077 | A Randomized Study of IVIG vs. IVIG With High Dose Methylprednisolone in Childhood ITP. | autoimmune thrombocytopenic purpura | Methylprednisolone (NPC144956) | NP level |
NCT01039103 | Nanocort in Acute Exacerbation of Relapsing-Remitting Multiple Sclerosis (MS) | relapsing-remitting multiple sclerosis | Methylprednisolone (NPC144956) | NP level |
NCT02006706 | A Study of MabThera/Rituxan (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis and Inadequate Response to DMARD Therapy | rheumatoid arthritis | Methylprednisolone (NPC144956) | NP level |
NCT00908713 | Corticoids in Severe Community-Acquired Pneumonia (CAP) | pneumonia | Methylprednisolone (NPC144956) | NP level |
NCT01957631 | Comparing Steroid Injections and Platelet Rich Plasma Injections in the Treatment of Plantar Fasciitis | Plantar Fasciitis | Methylprednisolone (NPC144956) | NP level |
NCT03674099 | Imatinib for Multiple Sclerosis (MS) Relapses | multiple sclerosis | Methylprednisolone (NPC144956) | NP level |
NCT00057811 | Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma | anaplastic large cell lymphoma;Burkitts lymphoma;diffuse large B-cell lymphoma;childhood acute lymphoblastic leukemia | Methylprednisolone (NPC144956) | NP level |
NCT02439866 | Outcomes of Steroid and Oxygen Therapy Versus Placebo Therapy in Non-arteritic Anterior Ischemic Optic Neuropathy | anterior ischemic optic neuropathy | Methylprednisolone (NPC144956) | NP level |
NCT00022126 | Combination Chemotherapy With or Without Donor Bone Marrow Transplantation in Treating Infants With Previously Untreated Acute Lymphoblastic Leukemia | leukemia | Methylprednisolone (NPC144956) | NP level |
NCT04833374 | Steroids Therapy in IgA Nephropathy With Crescents | IGA glomerulonephritis | Methylprednisolone (NPC144956) | NP level |
NCT03236662 | (-)- Epicatechin Becker Muscular Dystrophy | Becker muscular dystrophy | (-)-Epicatechin (NPC126029) | NP level |
NCT03758014 | Studies of Chlorogenic Acid for Injection for Safety and Efficacy of Grade IV GBM Patients | glioblastoma multiforme | Chlorogenic Acid (NPC302857) | NP level |
NCT03989271 | Biological Effects of Quercetin in COPD | chronic obstructive pulmonary disease | Quercetin (NPC20791) | NP level |
NCT01912820 | Effect of Quercetin on Green Tea Polyphenol Uptake in Prostate Tissue From Patients With Prostate Cancer Undergoing Surgery | prostate adenocarcinoma | Quercetin (NPC20791) | NP level |
NCT02962284 | One-year, Open Extension to Evaluate the Treatment of Patients With Castration-Resistant Prostate Cancer With YONSA™ | metastatic prostate cancer | Methylprednisolone (NPC144956) | NP level |
NCT04981912 | Rituximab + High-Dose Methylprednisolone Debulking Prior to Venetoclax for CLL & SLL Patients | chronic lymphocytic leukemia | Methylprednisolone (NPC144956) | NP level |
NCT02535039 | Methylprednisolone Combined Electric-acupuncture on Cognitive Function | Cognitive impairment | Methylprednisolone (NPC144956) | NP level |
NCT01392833 | Steroids and Azathioprine in Advanced IgAN | chronic kidney disease;IGA glomerulonephritis | Methylprednisolone (NPC144956) | NP level |
NCT04853199 | Quercetin In The Treatment Of SARS-COV 2 | COVID-19 | Quercetin (NPC20791) | NP level |
NCT00008307 | Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic Disorders | myelodysplastic syndrome;leukemia;multiple myeloma | Methylprednisolone (NPC144956) | NP level |
NCT00393367 | Budesonide Inhalation Suspension for Acute Asthma in Children | asthma | Methylprednisolone (NPC144956) | NP level |
NCT00554502 | Supportive Versus Immunosuppressive Therapy for the Treatment Of Progressive IgA Nephropathy | IGA glomerulonephritis | Methylprednisolone (NPC144956) | NP level |
NCT00053976 | Methylprednisolone With or Without Daclizumab in Treating Patients With Acute Graft-Versus-Host Disease | graft versus host disease | Methylprednisolone (NPC144956) | NP level |
NCT00418145 | Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks | multiple sclerosis | Methylprednisolone (NPC144956) | NP level |
NCT00003215 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma | lymphoma | Methylprednisolone (NPC144956) | NP level |
NCT01907204 | Evaluation of Inhaled Treatment in Sinusitis | sinusitis | Methylprednisolone (NPC144956) | NP level |
NCT00480298 | Double-Blind Randomized Placebo-Controlled Trial on Clinical and Biological Effects of Oral Corticosteroids or Doxycyclin in Patients With Nasal Polyposis | Nasal Cavity Polyp | Methylprednisolone (NPC144956) | NP level |
NCT00891306 | Efficacy and Safety of Human Lipoprotein Lipase (LPL)[S447X] Expressed by an Adeno-Associated Viral Vector in LPL-deficient Subjects | familial lipoprotein lipase deficiency | Methylprednisolone (NPC144956) | NP level |
NCT00053105 | Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma | lymphoma | Methylprednisolone (NPC144956) | NP level |
NCT03529929 | Glucocorticoid Inflammation Paradox in Human Skeletal Muscle | aging | Methylprednisolone (NPC144956) | NP level |
NCT01408836 | Plasma Exchange for Renal Vasculitis | Granulomatosis with Polyangiitis;microscopic polyangiitis | Methylprednisolone (NPC144956) | NP level |
NCT00424489 | Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis | Myasthenia gravis | Methylprednisolone (NPC144956) | NP level |
NCT00732498 | Rituximab, Yttrium Y 90 Ibritumomab Tiuxetan in Patients W/Relapsed Stage II, III, or IV Follicular NHL | lymphoma | Methylprednisolone (NPC144956) | NP level |
NCT00539838 | A Study to Evaluate Two Doses of Ocrelizumab in Patients With Active Systemic Lupus Erythematosus (BEGIN) | systemic lupus erythematosus | Methylprednisolone (NPC144956) | NP level |
NCT01438320 | Q-Trial in Patients With Hepatitis C | chronic hepatitis C virus infection | Quercetin (NPC20791) | NP level |
NCT03661567 | Methylprednisolone After Split-course Chemoradiotherapy For Bulky Local Advanced None-small Cell Lung Cancer | non-small cell lung carcinoma | Methylprednisolone (NPC144956) | NP level |
NCT00004904 | Stem Cell Transplantation in Treating Patients With Hematologic Cancer | chronic myeloproliferative disorder;myelodysplastic syndrome;graft versus host disease;leukemia;multiple myeloma | Methylprednisolone (NPC144956) | NP level |
NCT01783847 | Traumatic Optic Neuropathy Treatment Trial (TONTT) | optic nerve disorder | Methylprednisolone (NPC144956) | NP level |
NCT04733534 | An Open-Label Intervention Trial to Reduce Senescence and Improve Frailty in Adult Survivors of Childhood Cancer | childhood cancer | Quercetin (NPC20791) | NP level |
NCT00248534 | Rituximab, Temozolomide, and Methylprednisolone in Treating Patients With Recurrent Primary CNS Non-Hodgkin's Lymphoma | lymphoma | Methylprednisolone (NPC144956) | NP level |
NCT02848131 | Senescence in Chronic Kidney Disease | chronic kidney disease | Quercetin (NPC20791) | NP level |
NCT05317624 | Ultrasound Guided Steroids Injection Versus PRP for Shoulder Pain Relief | Shoulder pain | Methylprednisolone (NPC144956) | NP level |
NCT02444728 | Cyclophosphamide and Hydroxychloroquine for Thrombocytopenia in SLE | Thrombocytopenia | Methylprednisolone (NPC144956) | NP level |
NCT02351622 | Caffeic Acid Tablets as a Second-line Therapy for ITP | autoimmune thrombocytopenic purpura | Caffeic Acid (NPC294902) | NP level |
NCT04341038 | Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung Injury | COVID-19 | Methylprednisolone (NPC144956) | NP level |
NCT02098330 | The Efficacy of Steroid Therapy in Vestibular Neuritis | vestibular neuronitis | Methylprednisolone (NPC144956) | NP level |
NCT01181258 | Penostatin, Rituximab and Ontak and Allogeneic Natural Killer (NK) Cells for Refractory Lymphoid Malignancies | chronic lymphocytic leukemia | Methylprednisolone (NPC144956) | NP level |
NCT00309218 | Steroid Withdrawal in Pediatric Renal Transplant Recipients Under Cyclosporine (CyA) and Mycophenolate Mofetil (MMF) | kidney disease | Methylprednisolone (NPC144956) | NP level |
NCT02199041 | Combined T Cell Depleted Haploidentical Peripheral Blood Stem Cell and Unrelated Umbilical Cord Blood Transplantation in Patients With Hematologic Malignancies Using a Total Lymphoid Irradiation Based Preparative Regimen | lymphoid neoplasm | Methylprednisolone (NPC144956) | NP level |
NCT04666129 | Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate Cancer | prostate cancer | Methylprednisolone (NPC144956) | NP level |
NCT00003728 | Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma | leukemia;lymphoma | Methylprednisolone (NPC144956) | NP level |
NCT01468415 | Efficiency Comparison Between Methylprednisolone and Phenol 8% Treatment Using a Trans Sacral Approach - on Lower Back Pain and Limbs | Back pain | Phenol (NPC100980) | NP level |
NCT01354483 | Umbilical Cord Blood Mononuclear Cell Transplant to Treat Chronic Spinal Cord Injury | Spinal cord injury | Methylprednisolone (NPC144956) | NP level |
NCT04900948 | Prevention of Development of Transcutaneous Sensitization in Children With Atopic Dermatitis During Their First Year of Life | atopic eczema | Methylprednisolone (NPC144956) | NP level |
NCT01752790 | Efficacy and Safety of Top-down Therapy in Pediatric Crohn's Disease | Crohn's disease | Methylprednisolone (NPC144956) | NP level |
NCT05303792 | Testing the Combination of Inotuzumab Ozogamicin and Lower Dose Chemotherapy Compared to Usual Chemotherapy for Adults With B-Cell Acute Lymphoblastic Leukemia or B-Cell Lymphoblastic Lymphoma | acute lymphoblastic leukemia;lymphoblastic lymphoma | Methylprednisolone (NPC144956) | NP level |
NCT00367497 | Safety and Efficacy Study of Salvage Chemotherapy (R-ESHAP) to Treat Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma | non-Hodgkins lymphoma | Methylprednisolone (NPC144956) | NP level |
NCT00002831 | Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous or Acute Leukemia | leukemia | Methylprednisolone (NPC144956) | NP level |
NCT00199576 | Prevention of Post-Extubation Laryngeal Edema With Intravenous Corticosteroids | edema | Methylprednisolone (NPC144956) | NP level |
NCT04474626 | Isoquercetin in Sickle Cell Anemia | sickle cell anemia | Isoquercetin (NPC179950) | NP level |
NCT00066469 | Cyclophosphamide, Rituximab, and Either Prednisone or Methylprednisolone in Treating Patients With Lymphoproliferative Disease After Solid Organ Transplantation | lymphoproliferative syndrome | Methylprednisolone (NPC144956) | NP level |
NCT03913559 | Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia | acute lymphoblastic leukemia | Methylprednisolone (NPC144956) | NP level |
NCT00554710 | Top Down Versus Step Up Strategies in Crohn's Disease | Crohn's disease | Methylprednisolone (NPC144956) | NP level |
NCT02583594 | A Study to Characterize Subcutaneous or Intravenous Alemtuzumab in Patients With Progressive Multiple Sclerosis | multiple sclerosis | Methylprednisolone (NPC144956) | NP level |
NCT01773616 | Trial of Rituximab and Mycophenolate Mofetil Without Oral Steroids for Lupus Nephritis | systemic lupus erythematosus | Methylprednisolone (NPC144956) | NP level |
NCT00258427 | Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia | Fanconi anemia | Methylprednisolone (NPC144956) | NP level |
NCT04907253 | Quercetin in Coronary Artery By-pass Surgery | coronary artery disease | Quercetin (NPC20791) | NP level |
NCT01809132 | Efficacy Study of Anakinra, Pentoxifylline, and Zinc Compared to Methylprednisolone in Severe Acute Alcoholic Hepatitis | Hepatitis, Alcoholic | Methylprednisolone (NPC144956) | NP level |
How do we define the Plant-Targeted Human Disease Association?
Associated human diseases of an individual plant are summurized based on FOUR types of association evidence, these include:
❶ Association by Therapeutic Target: Bioactive protein targets of the plant were defined in "Molecular Targets" section, target-disease associations collected from TTD database were subsequently used to build the associations between the plant and its targeted human diseases.
❷ Association by Disease Gene Reversion: Plant and a specific disease will be associated when >= 1 plant target gene overlaped with disease's DEGs.
❸ Association by Clinical Trials of Plant: Plant and a specific disease will be associated when >= 1 clinical trial (the plant is the intervetion) can be matched in ClinicalTrials.gov database.
❹ Association by Clinical Trials of Plant Ingredients: Plant and a specific disease will be associated when >= 1 clinical trial (the plant ingredient is the intervetion) can be matched in ClinicalTrials.gov database.
Associated Disease of the Plant |
Association Type & Detailed Evidence |
---|---|
Acute myeloid leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A60 |
AURKB,AXL,SRC,TP53,TOP2A,NFKB1,KDM1A,FLT3,PIM1
|
Malignant haematopoietic neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B33 |
KDM1A,TP53,TOP2A,CDK1,AURKB,FLT3,SRC,DPP4
NCT02944045 |
LeishmaniasisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F54 |
NOX4,MMP1,MMP9,FLT3,ALPL,MMP2,DPP4,TSHR,AKR1B1
|
Malignant neoplasms of oesophagusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B70 |
CDK1,NPSR1,NOX4,MMP1,MMP9,AURKB,ALOX15,ACHE,TOP2A
|
Cytomegaloviral diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D82 |
ELAVL3,CYP2C9,MMP9,ALOX15,CYP1A1,ACHE,KDM4E,OPRD1,CA2
|
Invasive carcinoma of breastDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C61 |
CDK1,MMP1,ELAVL3,MMP9,AURKB,CA9,CA12,TOP2A,OPRD1
|
Lupus erythematosusDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A40 |
NFKB1
NCT02550652,NCT00282347,NCT00423098,NCT01085097,NCT05039619,NCT02260934,NCT04221477 |
Crohn diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD70 |
MMP9
MMP1,ALPL,MMP9 NCT04224558,NCT00554710,NCT01752790,NCT03219359 |
Other specified malignant neoplasms ofcolonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90.Y |
NPSR1,NOX4,CYP1A1,CA9,OPRD1,TYR,MMP1,MET
|
Other specified malignant neoplasms of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.Y |
CDK1,XDH,MMP1,MMP9,AURKB,CA9,CA12,TOP2A
|
Colorectal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B91 |
EGFR,KDR,MET,IGF1R,TP53,FLT3,TOP2A
|
Pain, unspecifiedDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG3Z |
OPRD1,IGF1R,AKR1B1,ACHE,ALOX5
NCT03564106,NCT05324748 |
Renal cell carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90 |
MMP9,MET,MMP2,CA9,KDR,EGFR
NCT02446795 |
Pancreatic cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10 |
MMP2,TP53,MMP1,IGF1R,TOP2A,SRC,EGFR
|
Ovarian cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73 |
TOP2A,FLT3,TP53,SRC,MET,KDR
NCT01105650 |
Osteoarthritis, unspecifiedDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA0Z |
CDK1,MMP9,HSD17B2,ALPL,MMP2,CA12,TOP2A
|
Renal cell carcinoma, chromophobe typeDisease Category: X.Extension CodesDisease ICD-11 Code: XH6153 |
MET,AURKB,CYP1A2,CYP1A1,CA12,TOP2A,CA2
|
Prostate cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82 |
AURKB,NR3C1
NCT01705652,NCT04666129,NCT02887976,NCT00003682 |
PsoriasisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA90 |
DPP4,AHR,FLT3,NFKB1,TOP2A,ALOX5
|
Atopic eczemaDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA80 |
NR3C1,NR3C1,NFKB1,AHR,ALOX5
NCT04900948 |
Liver cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12 |
MET,IGF1R,CSNK2A1,KDR,TOP2A,EGFR
|
Stomach cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72 |
MET,KDR,TOP2A,MMP9,TP53,EGFR
|
Alzheimer diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A20 |
MET,ACHE,SNCA,FLT3,TOP2A,KDR
|
AsthmaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA23 |
TOP2A,ALOX5,NR3C1,CA4
NCT02584738,NCT00393367 |
Nephritic syndromeDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB40 |
NCT01392833,NCT00554502,NCT02532777,NCT01197040,NCT00657059,NCT04833374
|
Chronic lymphocytic leukaemia or small lymphocytic lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A82.0 |
NCT01181258,NCT01465334,NCT04981912,NCT01497496,NCT01496976,NCT00558181
|
Malignant neoplasm metastasis in lymph nodes of head, face or neckDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D60.0 |
NPSR1,NOX4,MMP1,MMP9,AURKB,CA9
|
West Nile virus infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D46 |
MET,NFKB1,DPP4,CYP19A1,ACHE,AXL
|
Superficial ovarian endometriosisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA10.B4 |
SNCA,CA4,SRC,DPP4,ACHE,CA2
|
Chikungunya virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D40 |
XDH,EGFR,HIF1A,MMP2,CYP19A1,AXL
|
Bacterial infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A00-1C4Z |
TOP2A,CA4,CA12,CA2,CYP2C9
|
GlaucomaDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9C61 |
CA2,ACHE,MET,AKR1B1,CA4
|
MelanomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30 |
TYR,EGFR,KDR,MET
NCT00623766 |
Acute diabete complicationDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A2Y |
DPP4,KDR,NR3C1,AURKB,AKR1B1
|
Diffuse large B-cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A81 |
FLT3,TOP2A
NCT00057811,NCT02060656,NCT00482053 |
Chronic rhinosinusitisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA0A |
MMP1,MMP9,CA9,CYP1A1
NCT01907204 |
Precursor cell lymphoblastic leukaemia, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH5J37 |
NCT00057811,NCT04873583,NCT03913559,NCT00720109,NCT05303792
|
Congenital aplastic anaemiaDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3A70.0 |
NCT00630253,NCT00005898,NCT01720147,NCT01331018,NCT00258427
|
Carpal tunnel syndromeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C10.0 |
CYP1B1,NOX4,MMP2,DPP4
NCT00806871 |
Systemic sclerosisDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A42 |
MMP1,NOX4
NCT03593902,NCT00379431,NCT01445821 |
Injury of spinal cord, level unspecifiedDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: ND51.2 |
NCT01354483,NCT00004759,NCT04988425,NCT01046786,NCT00561067
|
Relapsing-remitting multiple sclerosisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A40.0 |
NCT03342638,NCT00984984,NCT03387046,NCT01039103,NCT01071083
|
Restrictive ophthalmopathyDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9C82.3 |
NCT00595335,NCT02422368,NCT01114503,NCT04876534,NCT04936854
|
Head and neck cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D42 |
KDR,EGFR,MET,TP53
|
ThrombocytopeniaDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3B64 |
AHR,ALOX5,KDR
NCT02444728 |
Mature B-cell leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A82 |
TP53,SRC,AXL,EGFR
|
Non-small cell lung cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25 |
MET,EGFR,KDR
NCT03661567 |
Chronic obstructive pulmonary diseaseDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA22 |
NR3C1
NCT04163536,NCT01708278,NCT03989271 |
Chronic painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG30 |
EGFR,KDR,FLT3,OPRD1
|
Peritoneal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C51 |
TP53,KDR,FLT3,SRC
|
Type 2 diabetes mellitusDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A11 |
NFKB1,NR3C1,DPP4
NCT01839344 |
NADisease Category: NADisease ICD-11 Code: NA |
NOX4,MET
NCT00427388,NCT05220319 |
Myeloproliferative neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A20 |
KDM1A,SRC,FLT3
NCT00002718 |
ParkinsonismDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A00 |
SNCA,ACHE,SRC
NCT04127578 |
Granulomatosis with polyangiitisDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A44.A1 |
NCT00753103,NCT00104299,NCT00307645,NCT01408836
|
Cardiac arrestDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MC82 |
NCT03640949,NCT00729794,NCT05139849,NCT02790788
|
Unspecified malignant neoplasms of unspecified sitesDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D4Z |
NCT02245204,NCT04733534,NCT00357084,NCT02136342
|
Microscopic polyangiitisDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A44.A0 |
NCT00753103,NCT00307645,NCT00104299,NCT01408836
|
Inflammatory bowel diseases, unspecifiedDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD7Z |
MMP1,ALPL,NOX4,MMP9
|
Melanoma of skinDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30 |
NR1I2,NOX4,IGF1R,ABCG2
|
Ebola virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D60.01 |
HSD17B2,MET,AXL,ACHE
|
Mesothelioma of pleuraDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C26.0 |
AHR,KDR,MMP9,CA12,TOP2A,CA7,EGFR,TDP1,FLT3,AURKB,PIM1,CA9,OPRD1,TYR,AXL,CSNK2A2,CDK1,XDH,MMP1,HSD17B2,SRC,CASP6,ALOX5,MET,SNCA,SMN1,APEX1,DPP4,ALOX15,RECQL
|
Thyroid cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D10 |
KDR,MET,TSHR
|
Chronic arterial occlusive diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD4Z |
TP53,DPP4,MET
|
Postoperative inflammationDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A00-CA43 |
NR3C1,ALOX5,SRC
|
Pulmonary hypertensionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BB01 |
HIF1A
NCT01690676,NCT01880866 |
RetinopathyDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B71 |
IGF1R,NR3C1,APEX1
|
Pleomorphic sarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B54 |
KDR,MET,SRC
|
Metastatic lymph node neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D60 |
EGFR,KDR,MET
|
Mature B-cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A85 |
TOP2A,FLT3,CDK1
|
Irritable bowel syndromeDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD91 |
NFKB1,ABCG2,OPRD1
|
Cardiovascular diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA00-BE2Z |
KDR,SRC,MET
|
Nasopharyngeal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6B |
EGFR,CDK1,ALOX5
|
Seborrhoeic dermatitisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA81 |
CA12,CA2,CA4
|
Fallopian tube cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C74 |
TP53,SRC
NCT01105650 |
InfluenzaDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E30-1E32 |
ALOX5,XDH,GLO1
|
Ulcerative colitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD71 |
MMP9
NCT01941589,NCT02921555 |
Shoulder lesionDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FB53 |
NCT02283996,NCT03479502,NCT05317624
|
Ageing associated decline in intrinsic capacityDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG2A |
NCT03529929,NCT05422885,NCT04946383
|
Immune thrombocytopenic purpuraDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3B64.10 |
NCT00376077,NCT02351622,NCT02757196
|
PneumoniaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA40 |
NCT02552342,NCT00908713,NCT03852537
|
Anaplastic large cell lymphoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH1LC0 |
NCT00057811,NCT01719835,NCT00310128
|
Becker muscular dystrophyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C70.0 |
NCT01856868,NCT04386304,NCT03236662
|
Aplastic anaemiaDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3A70 |
NCT01624805,NCT00004323,NCT02462252
|
Adenocarcinoma of prostateDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82.0 |
NOX4,ALOX15
NCT01912820 |
Neuromyelitis opticaDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A43 |
NCT00787722,NCT02087813,NCT03829566
|
Primary haemophagocytic lymphohistiocytosisDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A01.23 |
NCT02912702,NCT02631109,NCT04077905
|
Coeliac diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA95 |
CDK1,TSHR,CYP1A1
|
Myelodysplastic syndromes, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A3Z |
TSHR,PIM1,CYP2C9
|
Dengue fever, unspecifiedDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D2Z |
AURKB,NR1I2,ABCG2
|
Human immunodeficiency virus disease without mention of tuberculosis or malariaDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1C62 |
FLT3,MET,AXL
|
Gliomas of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.0 |
NOX4,AHR,MMP9
|
Carcinosarcoma of uterusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.43 |
NPSR1,MMP9,ALPL,TOP2A,CA7,NR1I2,TDP1,POLB,AURKB,KDM1A,CA9,HSD17B10,AKR1B1,OPRD1,GLO1,YES1,TP53,XDH,CISD1,MMP1,HSD17B2,CYP19A1,CA2,CASP6,MET,ELAVL3,DPP4,TSHR,ALOX15
|
Diffuse large B-cell lymphomasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A81 |
NOX4,AHR,KDR,ACHE,CA12,TOP2A,NR1I2,EGFR,TDP1,AURKB,MMP2,KDM1A,CA9,HSD17B10,AKR1B1,AXL,CSNK2A2,CDK1,GLO1,TP53,CISD1,MMP1,SRC,CASP6,MET,SMN1,APEX1,TSHR,RECQL
|
Solid tumour/cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00-2F9Z |
KDM1A,HIF1A,TP53,AHR,CA12,TOP2A,CA2,IGF1R,FLT3,ALOX5,YES1,SRC,XDH,KDR,POLB,AURKB,NFKB1,CA4,MMP9,MET,CSNK2A1,EGFR,AXL,NR3C1,PIM1,CDK1,APEX1,CA9
|
Serous cystadenoma,borderline malignancy of ovaryDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73.4 |
ALOX12,NOX4,AHR,MMP9,ALPL,CA12,NR1I2,TDP1,CYP1A2,CA9,OPRD1,GLO1,YES1,TP53,XDH,CISD1,MMP1,HSD17B2,CA2,CASP6,ALOX5,CSNK2A3,MET,ELAVL3,APEX1,TSHR,ALOX15
|
Adenocarcinoma of pancreasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.0 |
NPSR1,ACHE,CA7,NR1I2,POLB,AURKB,PIM1,MMP2,CA9,AXL,XDH,CISD1,MMP1,HIF1A,HSD17B2,CA2,ALOX5,ABCG2,CYP1B1,MET,SNCA,CYP2C9,DPP4,ALOX15,RECQL
|
Germ cell tumour of testisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C80.2 |
NPSR1,ALOX12,NOX4,AHR,KDR,ACHE,CA12,MMP2,AKR1B1,OPRD1,GLO1,CDK1,XDH,MMP1,HIF1A,HSD17B2,ALOX5,CASP6,ABCG2,MET,SNCA,CA4,CYP2C9,SMN1,DPP4
|
Rheumatoid arthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA20 |
ABCG2,NFKB1,MMP9,NR3C1,AKR1B1,CA2,ALOX5,MMP1,OPRD1
NCT00243412,NCT00634933,NCT02093026,NCT00578305,NCT00396747,NCT00299130,NCT01219933,NCT01000610,NCT00298272,NCT01382940,NCT01390441,NCT01308255,NCT00808210,NCT02006706,NCT00299104 |
Multiple sclerosisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A40 |
NR3C1,SRC,TOP2A,NFKB1
NCT00241254,NCT02545959,NCT01838174,NCT04544436,NCT03674099,NCT03368664,NCT00947895,NCT02583594,NCT01710228,NCT01049451,NCT02784210,NCT02769689,NCT04548999,NCT00017628,NCT00753792,NCT01305837,NCT01986998,NCT00418145 |
LeukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A60-2B33 |
NCT01005914,NCT00553202,NCT00022126,NCT01005758,NCT00004904,NCT00458848,NCT00400946,NCT00002785,NCT01228331,NCT00006451,NCT00609739,NCT00008307,NCT00003336,NCT00003728,NCT00004034,NCT00002534,NCT00003960,NCT00002718,NCT00004232,NCT00002831,NCT00003187,NCT00002471
|
Mature T-cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A90 |
TOP2A,EGFR,KDM1A,HIF1A,CA9
NCT00003215,NCT00002471,NCT00003728,NCT00002835,NCT00920153,NCT00002718,NCT00053105,NCT00248534,NCT00003650,NCT00109928,NCT00069966,NCT00002565,NCT00003187,NCT00732498,NCT00577993,NCT00006451 |
Other specified malignant neoplasms of kidney, except renal pelvisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90.Y |
MMP9,ACHE,TOP2A,AURKB,CA9,OPRD1,TYR,XDH,CYP19A1,ALOX5,MET,CYP2C9,MMP1,MMP9,AURKB,TSHR,CA9,TOP2A,OPRD1,ALOX5
|
Hepatocellular carcinoma of liverDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.02 |
CDK1,NOX4,MMP1,CA4,MMP9,AURKB,CA9,CYP19A1,CA12,TOP2A,L3MBTL1,CDK1,MMP1,MMP9,AURKB,SRC,CA9,CYP19A1,CA12,TOP2A
|
Motor neuron diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B60 |
IGF1R,SRC
|
Indeterminate colitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD72 |
NR3C1,NFKB1
|
NeuropathyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C0Z |
AKR1B1,CYP19A1
|
Bladder cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94 |
TP53,TOP2A
|
IschemiaDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B10-8B11 |
EGFR,SRC
|
Muscular atrophyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B61 |
SMN1,SMN2
|
Heart failureDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD10-BD1Z |
XDH,CA2
|
Otitis externaDisease Category: 10.Diseases of the ear or mastoid processDisease ICD-11 Code: AA00-AA13 |
NR3C1,TOP2A
|
Coronavirus infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D92 |
CSNK2A1
NCT04323592 |
Muscular dystrophyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C70 |
NFKB1,NR3C1
|
Pituitary gland disorderDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A60-5A61 |
ALOX5,IGF1R
|
Colon cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90 |
EGFR,ALPL
|
Cushing syndromeDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A70 |
NR3C1,CYP19A1
|
OesophagitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA24 |
CYP19A1,NR3C1
|
BCR-ABL1-negative chronic myeloid leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A41 |
SRC,FLT3
|
Cervical cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C77 |
SRC,TP53
|
Idiopathic interstitial pneumonitisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB03 |
ALOX5,FLT3
|
Esophageal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B70 |
TP53
NCT04648917 |
Ischemic heart diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA40-BA6Z |
MET
NCT00157014 |
Myasthenia gravisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C6Y |
ACHE
NCT00424489 |
Substance abuseDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C40 |
ACHE,NR3C1
|
Diabetes mellitus, type unspecifiedDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A14 |
NFKB1,DPP4
|
Endometrial cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76 |
TP53,SRC
|
Malignant digestive organ neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C11 |
KDR,SRC
|
Unspecific body region injuryDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: ND56 |
EGFR,MET
|
ThrombosisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB61-GB90 |
TOP2A,AKR1B1
|
Gastrointestinal stromal tumourDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B5B |
KDR,SRC
|
Follicular lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A80 |
TOP2A
NCT00455416 |
Vasomotor/allergic rhinitisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA08 |
NR3C1
NCT01989897 |
Fungal infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F29-1F2F |
NFKB1,ALOX5
|
Urinary tract infectionDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GC08 |
TOP2A
NCT02331862 |
Spinal painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: ME84 |
OPRD1
NCT01468415 |
Respiratory system diseaseDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB40-CB7Z |
TOP2A
NCT01283009 |
DementiaDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6D80-6D8Z |
ACHE
NCT04408625 |
Other specified deletions of chromosome 22Disease Category: 20.Developmental anomaliesDisease ICD-11 Code: LD44.NY |
NCT00579527,NCT01220531
|
Acute respiratory distress syndromeDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB00 |
NCT00000579,NCT03371498
|
VasculitisDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A44 |
NCT00307645,NCT03942887
|
Intermediate hyperglycaemia, unspecifiedDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A40.Z |
NCT02656212,NCT02330276
|
Malignant neoplasm metastasis in male genital organsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E06 |
NCT04787744,NCT02962284
|
Myeloproliferative neoplasm, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH5HH7 |
NCT00004232,NCT00004904
|
Drug-induced or toxic liver disease with chronic hepatitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB95.1 |
NCT03266146,NCT02651350
|
coronary artery diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA8Y-BA8Z |
NCT04907253,NCT03943459
|
Glioblastoma, primary, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH0MB1 |
NCT03758014,NCT02728349
|
Sickle-cell disorderDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3A51 |
NCT04474626,NCT04514510
|
PneumocystosisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F2G |
NCT00000741,NCT00000730
|
Other specified sphingolipidosisDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C56.0Y |
NCT04411654,NCT05487599
|
Other specified clinical findings in specimens from the urinary systemDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MF8Y |
NCT03018535,NCT00135967
|
Friedreich ataxiaDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A03.10 |
NCT02660112,NCT02424435
|
Severe acute respiratory syndromeDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D65 |
NCT04323592,NCT04499313
|
Malignant lymphoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH5FJ5 |
NCT00310128,NCT00002524
|
Zika virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D48 |
AXL,ACHE
|
Myotonic dystrophyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C71.0 |
TOP2A,CYP1A1
|
Tetralogy of FallotDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LA88.2 |
CA4,ABCG2
|
Pneumonia due to PseudomonasaeruginosaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA40.05 |
DPP4,MMP9
|
Heart failure, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD1Z |
CYP1B1,ABCG2
|
Lyme borreliosisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1C1G |
MET,MMP9
|
COVID-19Disease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D6Y |
NCT04603729,NCT04438980,NCT04909918,NCT04244591,NCT04853199,NCT04499313,NCT04345445,NCT04622865,NCT04673162,NCT04733651,NCT04355247,NCT05002517,NCT04323592,NCT04349410,NCT04329650,NCT04341038,NCT04485429,NCT04536090,NCT04851821
|
Graft-versus-host diseaseDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4B24 |
NCT00282503,NCT00771875,NCT02392780,NCT00136903,NCT00006451,NCT00609609,NCT00004904,NCT00053976,NCT00004232,NCT03701698,NCT02953678,NCT02176031,NCT04220632,NCT03994783,NCT05368181,NCT00043147,NCT02956122,NCT02614612,NCT03139604
|
Malignant neoplasms of biliary tract, distal bile ductDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C15 |
NOX4,ALOX12,MMP9,TOP2A,IGF1R,AURKB,MMP2,CA9,AKR1B1,CDK1,TP53,MMP1,HIF1A,SRC,ALOX5,L3MBTL1,CSNK2A3,CA4,ELAVL3
|
Multiple myelomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A83 |
FLT3,SRC,AHR,IGF1R,AXL,KDR
NCT00002599,NCT01332617,NCT00574288,NCT02294357,NCT03110822,NCT00008307,NCT01985126,NCT00004904,NCT00004232,NCT04519476,NCT00003960 |
Malignant neoplasms of adrenal glandDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D11 |
NOX4,MMP9,CA12,TOP2A,CA7,NR3C1,AURKB,CA9,GLO1,CDK1,MMP1,HSD17B2,CYP19A1,MET,SNCA,CA4,DPP4
|
Myelodysplastic syndromeDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A37 |
KDR,EGFR,TP53,AHR,AXL,KDM1A
NCT00003187,NCT00004904,NCT00003336,NCT00002718,NCT00003960,NCT00008307,NCT02462252,NCT00004232,NCT01624805 |
Breast cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C60-2C6Y |
CA4,TOP2A,IGF1R,CA9,AXL,CYP19A1,CA2,CA12,CDK1,NR3C1,MET,KDR,SRC,EGFR
NCT01105650 |
HepatoblastomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.01 |
NOX4,MMP9,CA12,TOP2A,IGF1R,AURKB,MMP2,AKR1B1,OPRD1,CDK1,MMP1,SRC,CYP19A1,L3MBTL1,CA4
|
Adenocarcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.0 |
NPSR1,MMP9,ACHE,CA12,TOP2A,CA7,NR1I2,AURKB,CA9,OPRD1,CDK1,XDH,MMP1,CYP2C9,TSHR
|
Lung cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25 |
TOP2A,MET,KDM1A,ALOX5,KDR,CDK1,AXL,MMP9,MMP1,FLT3,EGFR,MMP2,IGF1R
NCT03751592 |
Malignant neoplasms of corpus uteri, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.Z |
NPSR1,MMP9,ALPL,CYP1A1,TOP2A,AURKB,CA9,CDK1,XDH,MMP1,HSD17B2,CA2,CYP2C9,ALOX15
|
Malignant neoplasms of thymusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C27 |
MMP9,ACHE,FLT3,CA9,HSD17B10,AKR1B1,CISD1,NFKB1,HSD17B2,CYP1B1,CYP2C9,APEX1,DPP4,ALOX15
|
Squamous cell carcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.2 |
NPSR1,ALOX12,MMP9,CA12,TOP2A,CA7,AURKB,CA9,CDK1,XDH,MMP1,CYP2C9,TSHR
|
PheochromocytomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH3854 |
MET,XDH,NOX4,MMP1,SNCA,CA4,ELAVL3,MMP9,NR3C1,ACHE,OPRD1,CA2
|
Malignant neoplasms of thyroid gland, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D10.Z |
CYP1B1,GABRA6,MET,CA7,XDH,NOX4,MMP1,ALPL,DPP4,CA12,ALOX5
|
Brain cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00 |
KDR,SRC,HIF1A,MMP2,TOP2A,MMP9,TP53,MMP1,MET,EGFR
|
Chronic kidney diseaseDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB61 |
IGF1R,XDH
NCT00078559,NCT04629248,NCT02848131,NCT00309218,NCT01955187,NCT02552888,NCT00023244,NCT01392833 |
Systemic lupus erythematosusDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A40.0 |
YES1,MMP9,CYP1A1,ACHE
NCT00076752,NCT00539838,NCT00230035,NCT00381810,NCT01773616,NCT04963296 |
OsteoarthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA00-FA05 |
NCT05276895,NCT02292082,NCT02542592,NCT02576249,NCT02332603,NCT02445898,NCT02332616,NCT00977444,NCT02332629,NCT02319343
|
Adenocarcinoma of stomachDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72.0 |
NPSR1,NOX4,MMP9,TOP2A,AURKB,CDK1,MMP1,CYP19A1,MET,ALOX15
|
Urothelial carcinoma of bladderDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94.2 |
CDK1,AKR1B1,MMP1,CYP2C9,MMP9,CYP1A2,AURKB,CA9,TOP2A,CA2
|
Glioblastoma of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.00 |
KDR,CA12,CA9,CYP19A1,CA2,CYP1B1,MET,CSNK2A3,DPP4,TSHR
|
Inborn purine/pyrimidine/nucleotide metabolism errorDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C55 |
XDH
|
Ocular cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D00-2D07 |
APEX1
|
Common wartsDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E80 |
TOP2A
|
Acquired hypermelanosisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: ED60 |
TYR
|
CoughDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MD12 |
OPRD1
|
SyphilisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A61-1A6Z |
TOP2A
|
Spinal cord/cranial nerve neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A02 |
EGFR
|
MastocytosisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A21 |
FLT3
|
Kaposi sarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B57 |
TOP2A
|
GoutDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA25 |
XDH
|
Allergic/hypersensitivity disorderDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A80-4A8Z |
NR3C1
|
Inflammatory arthropathyDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA2Z |
FLT3
|
Angina pectorisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA40 |
EGFR
|
Biliary tract cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C17 |
MET
|
Skin and skin-structure infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F28-1G0Z |
NFKB1
|
AnxietyDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MB24.3 |
OPRD1
|
Ureteral cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C92 |
AHR
|
Coronary vasospastic diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA85 |
OPRD1
|
Adrenomedullary hyperfunctionDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A75 |
HIF1A
|
Ischaemic/haemorrhagic strokeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B20 |
MMP9
|
Mood disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A60-6E23 |
NR3C1
|
Adaptive immunity immunodeficiencyDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A01 |
NR3C1
|
Extraocular muscle disorderDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9C82 |
IGF1R
|
Hypopharyngeal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6D |
EGFR
|
Lip/oral cavity/pharynx neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6E |
TP53
|
Skin postprocedural disorderDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EL8Y |
EGFR
|
Kidney failureDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB60-GB6Z |
TP53
|
Genetic prion diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8E02 |
ALPL
|
MigraineDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A80 |
OPRD1
|
Hepatitis virus infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E50-1E51 |
EGFR
|
Bowel habit changeDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: ME05 |
OPRD1
|
Gonococcal infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A70-1A7Z |
TOP2A
|
Adrenogenital disorderDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A71 |
NR3C1
|
FilariasisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F66 |
ALOX5
|
Otitis mediaDisease Category: 10.Diseases of the ear or mastoid processDisease ICD-11 Code: AA80-AB0Z |
TOP2A
|
Unspecific substance harmful effectDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: NE6Z |
ACHE
|
Synovial sarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B5A |
SRC
|
Intracerebral haemorrhageDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B00 |
EGFR
|
Acquired hypomelanotic disorderDisease Category: 14.Diseases of the skinDisease ICD-11 Code: ED63 |
TYR
|
Parasitic infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D0Y-1G2Z |
ALPL
|
Metastatic liver/bile duct neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D80 |
TP53
|
LeiomyosarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B58 |
SRC
|
Digestive organ benign neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E92 |
KDR
|
Human immunodeficiency virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1C60-1C62 |
FLT3
|
ThyrotoxicosisDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A02 |
IGF1R
|
OsteosarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B51 |
SRC
|
Myocardial infarctionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA41-BA43 |
DPP4
|
SchizophreniaDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A20 |
AKR1B1
|
Chronic myelomonocytic leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A40 |
FLT3
|
PediculosisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1G00 |
ACHE
|
Epidermal dysplasiasDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EK90 |
SRC
|
Malignant mesenchymal neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B5D-2B5Y |
EGFR
|
Autonomic nervous system disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8D87 |
SNCA
|
Parasitic worm infestationDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F90 |
ACHE
|
Mineral deficiencyDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B5K |
XDH
|
Metastatic digestive system neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D8Y |
SRC
|
Vitamin deficiencyDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B55-5B5F |
NR3C1
|
CataractDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B10 |
AKR1B1
|
Oesophageal/gastroduodenal disorderDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD90 |
ACHE
|
Acne vulgarisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: ED80 |
MMP2
|
Opioid use disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C43 |
OPRD1
|
Hypo-thyroidismDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A00 |
TSHR
|
Mild neurocognitive disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6D71 |
ACHE
|
Anogenital wartsDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A95 |
TOP2A
|
Spine/trunk injuryDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: ND51 |
NR3C1
|
HIV-infected patients with tuberculosisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1B10-1B14 |
TOP2A
|
Unspecified viral infection of unspecified siteDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D9Z |
FLT3
|
Choreiform disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A01 |
NFKB1
|
Functional bladder disorderDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GC50 |
OPRD1
|
Acute/subacute hepatic failureDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB91 |
NFKB1
|
Diabetic foot ulcerDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD54 |
EGFR
|
Metastatic malignant neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D50-2E09 |
AXL
|
Ovarian dysfunctionDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A80 |
TP53
|
Transplanted organ/tissueDisease Category: 24.Factors influencing health status or contact with health servicesDisease ICD-11 Code: QB63 |
FLT3
|
Low bone mass disorderDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FB83 |
CA2
|
DepressionDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A70-6A7Z |
NR3C1
|
Phakomatoses/hamartoneoplastic syndromeDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LD2D |
FLT3
|
Carcinoid syndromeDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B10 |
ALOX5
|
Liver diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB90-DB9Z |
MET
|
Ewing sarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B52 |
KDM1A
|
EndometriosisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA10 |
CYP19A1
|
EncephalopathyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8E47 |
XDH
|
InsomniaDisease Category: 07.Sleep-wake disordersDisease ICD-11 Code: 7A00-7A0Z |
CA2
|
Herpes simplex infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F00 |
NR3C1
|
Multiple structural anomalies syndromeDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LD2F |
IGF1R
|
Hepatic fibrosis/cirrhosisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB93 |
MMP2
|
LiposarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B59 |
TP53
|
Metabolic disorderDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C50-5D2Z |
DPP4
|
Metastatic biliary tract neoplasmsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C14-2C17 |
EGFR
|
Duodenal ulcerDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA63 |
CA2
|
ChemoprotectionDisease Category: NADisease ICD-11 Code: N.A. |
TOP2A
|
Transplant rejectionDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: NE84 |
TP53
|
Urethral cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C93 |
EGFR
|
Autism spectrum disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A02 |
DPP4
|
Essential hypertensionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA00 |
CA2
|
Testicular cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C80 |
EGFR
|
Bone/articular cartilage neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2F7B |
FLT3
|
Vestibular neuritisDisease Category: 10.Diseases of the ear or mastoid processDisease ICD-11 Code: AB30.0 |
NCT02098330
|
Impaired glucose toleranceDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A40.1 |
NCT02621060
|
Epileptic encephalopathyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A62 |
NCT03876444
|
Optic nerve disorderDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9C40 |
NCT01783847
|
Chronic hepatitis CDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E51.1 |
NCT01438320
|
Psoriatic arthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA21 |
NCT03797872
|
Malignant lymphoma, not elsewhere classifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B33.5 |
NCT00367497
|
Cystic fibrosisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA25 |
NCT01348204
|
OedemaDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG29 |
NCT00199576
|
RadiculopathyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B93 |
NCT00733096
|
HyperlipidemiaDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C80 |
NCT05302388
|
Classical Hodgkin lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B30.1 |
NCT02166463
|
Bell palsyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B88.0 |
NCT00438087
|
Macular degenerationDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B75 |
NCT05062486
|
Amyotrophic lateral sclerosisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B60.0 |
NCT01884571
|
Gastro-oesophageal reflux diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA22 |
NCT02226484
|
Infection, unspecifiedDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1H0Z |
NCT00128180
|
Burkitt lymphoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH4KA9 |
NCT00057811
|
Noise effects on inner earDisease Category: 10.Diseases of the ear or mastoid processDisease ICD-11 Code: AB37 |
NCT02049073
|
Congenital cytomegalovirus infectionDisease Category: 19.Certain conditions originating in the perinatal periodDisease ICD-11 Code: KA62.3 |
NCT00966836
|
IgG4 related diseaseDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A43.0 |
NCT04918147
|
PulpitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA09.0 |
NCT04157036
|
TenosynovitisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FB40 |
NCT03704584
|
Juvenile dermatomyositisDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A41.01 |
NCT00323960
|
Developmental speech or language disordersDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A01 |
NCT05487521
|
Thrombotic thrombocytopenic purpuraDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3B64.14 |
NCT04074187
|
Abdominal pelvic painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MD81 |
NCT02002663
|
Malignant neoplasms of other or unspecified parts of mouthDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B66 |
NCT05456022
|
Duchenne muscular dystrophyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C70.1 |
NCT02964377
|
Optic neuritisDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9C40.1 |
NCT00000146
|
Alcoholic hepatitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB94.1 |
NCT01809132
|
Immune dysregulation syndromes presenting primarily with lymphoproliferationDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A01.22 |
NCT00066469
|
Angioimmunoblastic T-cell lymphomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH1J86 |
NCT01719835
|
Degenerative condition of spine, unspecifiedDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA8Z |
NCT01216631
|
NeoplasmsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 02 |
NCT00436761
|
Developmental language disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A01.2 |
NCT03308084
|
Cerebral ischaemic strokeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B11 |
NCT03249844
|
Meniere diseaseDisease Category: 10.Diseases of the ear or mastoid processDisease ICD-11 Code: AB31.0 |
NCT00802529
|
Lichen planusDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA91 |
NCT01375101
|
GangliosidosisDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C56.00 |
NCT03952637
|
Paraneoplastic or autoimmune disorders of the central nervous system, brain or spinal cordDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8E4A.0 |
NCT02282514
|
Immune system diseaseDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A01-4B41 |
NCT04294459
|
Neoplasms of haematopoietic or lymphoid tissues, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B3Z |
NCT02199041
|
Bronchopulmonary dysplasia originating in the perinatal periodDisease Category: 19.Certain conditions originating in the perinatal periodDisease ICD-11 Code: KB29.0 |
NCT00004785
|
Adult T-cell lymphoma or leukaemia, human T-cell lymphotropic virus type 1-associatedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A90.5 |
NCT03007147
|
HypertriglyceridaemiaDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C80.1 |
NCT00891306
|
MyocarditisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC42 |
NCT05150704
|
AppendicitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB10 |
NCT02711449
|
Coronary atherosclerosisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA80 |
NCT01647685
|
Other specified primary disorders of musclesDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C7Y |
NCT00278564
|
Anterior ischemic optic neuropathyDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9C40.40 |
NCT02439866
|
Traumatic subdural haemorrhageDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: NA07.6 |
NCT02650609
|
Mucocutaneous lymph node syndromeDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A44.5 |
NCT04509219
|
Symptoms and signs involving cognition, unspecifiedDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MB21.Z |
NCT02535039
|
Other specified nasal polypDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA0J.Y |
NCT00480298
|
Myeloproliferative and myelodysplastic disease, unclassifiableDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A44 |
NCT00003336
|
Primary progressive multiple sclerosisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A40.1 |
NCT05232825
|
Precursor B-lymphoblastic neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A70 |
NCT05303792
|
Peripheral T-cell lymphoma, not otherwise specifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A90.C |
NCT01719835
|
Ovarian hyperstimulation syndromeDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA32.0 |
NCT01014104
|
DysphagiaDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MD93 |
NCT03311425
|
Plantar fasciitisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FB40.1 |
NCT01957631
|
Skin tag/polypDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EK71 |
NCT02569437
|
Axial spondyloarthritis, unspecifiedDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA92.0Z |
NCT01790022
|
Other specified qualitative platelet defectsDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3B62.Y |
NCT05137496
|
Atrial fibrillationDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC81.3 |
CA7
|
Non-alcoholic fatty liver diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB92 |
MMP9
|
KeratoconusDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9A78.50 |
CA4
|
Pre-eclampsiaDisease Category: 18.Pregnancy, childbirth or the puerperiumDisease ICD-11 Code: JA24 |
CA4
|
Dilated cardiomyopathyDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC43.0 |
ABCG2
|
Malaria, unspecifiedDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F4Z |
MMP9
|